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ABSTRACT 
 
 This thesis explored the hypothesis that cytomegalovirus (CMV) infection and its 
reactivation may be a shared mechanism linking psychosocial and behavioral factors with 
the age-associated decline in immunity, known as immunosenescence. The first empirical 
chapter (Chapter 3) showed that psychological stress factors were positively associated 
with CMV reactivation, as measured by increased CMV-specific IgG antibodies (CMV-
IgG) among those infected, while socioeconomic and lifestyle factors were associated with 
CMV infection rates. Chapter 4 investigated personality traits and revealed that increased 
neuroticism predicted elevated odds of CMV infection and higher conscientiousness was 
associated with lower CMV-IgG levels. Chapter 5 demonstrated that more frequent 
physical activity was associated with lower levels of highly-differentiated T-cells, but this 
association was reduced to non-significance by adjustment for CMV infection. Chapter 6 
showed that dysregulated glucose metabolism, measured as higher glycated hemoglobin 
levels, was associated with increased highly-differentiated T-cells in CMV-infected 
individuals. Furthermore, hyperglycemia interacted with CMV infection for a further 
increased accumulation of these cells. In sum, these results suggest that CMV and 
psychosocial and behavioral factors co-determine the progression of immunosenescence, 
and that CMV reactivation may reflect imbalance among these factors. Thus, CMV 
reactivation is proposed as a common pathway in psychobiological relationships with 
immunosenescence.  
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CHAPTER 1 : GENERAL 
INTRODUCTION 
Introduction 
Epidemiological evidence demonstrates increased morbidity and mortality in 
populations exposed to adverse psychosocial factors such as low socioeconomic status and 
protracted psychological distress (Cohen & Herbert, 1996; House et al., 1988; Marmot, 
2005; Schneiderman et al., 2005). While the data is clear, the precise mechanisms 
underlying these associations have yet to be determined (Antoni et al., 2006; Cacioppo & 
Hawkley, 2003; Glaser & Kiecolt-Glaser, 2005; Mcewen, 1998; Uchino et al., 1996). It 
has been argued that since increasing age is a major risk factor for a wide range of chronic 
diseases, the aging process itself may be an important target for such mechanistic research 
(Bauer et al., 2013; Bosch et al., 2009; Nilsson, 1996).  
Immunoscenescence 
This thesis explores the human herpes virus, cytomegalovirus (CMV), as a possible 
biological pathway linking psychosocial stress and immunosenescence, which may 
underlie psychobiological associations with health (Bosch et al., 2009). 
Immunosenescence refers to a decline in immune competence seen in old age, and it is 
associated with a dramatic rise in morbidity and mortality from infectious disease (Akbar 
et al., 2004; Larbi et al., 2008). For example, the elderly exhibit a many-fold higher 
mortality from otherwise common infections such as gastrointestinal infections, urinary 
tract infections and influenza (Thompson et al., 2003; Yoshikawa, 2000). This 
susceptibility also promotes physical frailty and cognitive decline, further increasing 
mortality risk and reducing quality of life (High et al., 2005; Yoshikawa, 2000). Although 
less well established, immunosenescence may also be a factor in the age-related increase in 
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autoimmune and inflammatory disorders (Franceschi, Bonafe, et al., 2000; Hohensinner et 
al., 2011; Lindstrom & Robinson, 2010; Prelog, 2006).  
These clinical complications of immunosenescence mark the terminal phase of a 
process that already starts in adolescence (Akbar & Fletcher, 2005; Nikolich-Zugich, 
2008). Around that time the thymus, an organ essential for the maturation of T 
lymphocytes, reduces in size and function with a concomitant decline in the generation 
naive T-cells, partially due to increased circulating sex hormones during puberty (Appay et 
al., 2010; Palmer, 2013). This process causes immunity to become progressively 
dependent on the existing pool of naïve and memory T-cells (Woodland & Blackman, 
2006). The pool of memory T-cells gradually expands, compensating for the diminishing 
influx of naive T-cells via cytokine-induced cell division (denoted ‘homeostatic 
proliferation’) and repeated antigen exposure (Pawelec, 2012). In particular latent herpes 
viruses, like CMV, are a major source of continuous antigenic stimulation (Khan et al., 
2002; Nikolich-Zugich, 2008). Consequently, the expanding pool of memory cells tends to 
be oligoclonal, i.e., exhibit an antigen receptor diversity that is skewed towards a few 
immunodominant viral antigens. These changes are particularly prominent in CD8+ T 
lymphocytes (CTLs) and the accumulation of these oligoclonal T-cells is considered a 
hallmark of immunosenescence (Akbar & Fletcher, 2005; Hadrup et al., 2006; Pawelec, 
2006).  
T-cell phenotypes, their development, and functional characteristics 
The general observation is that repeated contact with the same antigen moves 
memory cells along a differentiation continuum whereby they gradually change their cell-
surface appearance, or phenotype, and acquire so-called ‘effector’ functions, such as 
increased cytotoxicity (as determined by granzyme and perforin expression), and attain a 
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preference to home to peripheral tissue (e.g., the skin and lungs) rather than the lymphoid 
tissue. Immunologists utilize various analytical strategies based on the staining of cell-
surface molecules to identify CD8+ T-cell ‘subsets’ at distinct stages of this differentiation 
process. The combination of the markers CD45RA (an isoform of the pan-lymphocyte 
marker CD45) and the co-stimulatory molecule, CD27 (gradually lost with increased 
differentiation), has been chosen for this thesis. This approach can be used to discern 
antigen inexperienced, or naive, cells (NA; CD27+CD45RA+), and three additional 
subsets of antigen-experienced (‘memory’) cells: central memory (CM; 
CD27+CD45RA−), effector memory (EM; CD27−CD45RA−) and effector memory cells 
which have re-expressed CD45RA (EMRA; CD27−CD45RA+) (Appay et al., 2008; 
Hamann et al., 1997; Sallusto et al., 2004; Sallusto et al., 1999; Van Lier et al., 2003). This 
method of subset identification was chosen because the EMRA T-cell phenotype is 
associated almost exclusively with CMV infection, and may reflect recent CMV activity 
(Cantisán et al., 2010; Chidrawar et al., 2009; Derhovanessian et al., 2011; Kuijpers et al., 
2003; Turner et al., 2014; Van De Berg et al., 2008; Van Lier et al., 2003). The EM and 
EMRA subsets have undergone several rounds of cell division and are considered to be 
highly-differentiated T-cells.  
Highly-differentiated T-cells contribute to features of immunosenescence 
Markers of an aging adaptive immune system include weakened cell-mediated and 
humoral responses to vaccination, a diminished proliferative response to mitogens, a 
reduced production of interleukin-2 (IL-2; which stimulates the growth, differentiation and 
survival of cytotoxic T-cells), shortening of leukocyte telomeres (a DNA marker of 
cellular aging), increased serum levels of inflammatory cytokines like tumor necrosis 
factor alpha (TNF-α), persistent reactivation of latent herpes viruses, e.g., Epstein-Barr 
Virus (EBV) and CMV, and a reduced CD4:CD8 ratio (Effros, 2007; Goronzy & Weyand, 
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2013; Larbi et al., 2008; Luz Correa et al., 2014; Pawelec, 2006; Strindhall et al., 2012; 
Turner et al., 2014). Significantly, all of the aforementioned immune changes that 
characterize aging are, in part, a result of the accumulation of T-cells with a differentiated 
phenotype (i.e., EM and EMRA); that is, these T-cells poorly proliferate in response to 
mitogens, produce little IL-2, but abundant inflammatory interferon gamma (IFN-γ), have 
very short telomeres, expand in response to repeated latent viral reactivation and the 
number of these cells correlate with weaker vaccination responses (Monteiro et al., 1996; 
Nikolich-Zugich, 2008; Van De Berg et al., 2010).  
Stress effects parallel those of immune aging 
Those who are familiar with the psychoneuroimmunology literature may 
immediately note a striking similarity between the immune changes summarized in the 
previous paragraph and the immune effects of chronic stress (Bosch et al., 2009). Indeed, 
meta-analysis has shown that protracted psychosocial stressors are associated with much 
the same pattern of weakened responses to immunization, diminished proliferation to 
mitogens, reduced IL-2 production, and reactivation of latent herpes viruses (Segerstrom & 
Miller, 2004). Other distinctive features of immunosenescence, such as elevated serum 
levels of inflammatory markers and shortened leukocyte telomeres, have also consistently 
been associated with psychosocial stress (Damjanovic et al., 2007; Epel et al., 2004; Glaser 
& Kiecolt-Glaser, 2005; Simon et al., 2006). The remarkable parallels between the aging 
and stress literature leads one to hypothesize that psychosocial stress contributes to the 
process of immunological aging (Bosch et al., 2009). Thus, the hypothesis explored in the 
current thesis is that the effects of stress and aging on immunity not only just look the 
same, but may also share similar pathways. Moreover, it will be argued that one of these 
shared pathways may be the effects of cytomegalovirus infection on immunity. The 
sections that follow will describe how CMV infection dramatically alters the composition 
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of the blood, causing an accumulation of highly-differentiated CD8+ T-cells (CD27–); a 
hallmark of an aging immune system. 
Cytomegalovirus infection and immunity 
It is thought that this CMV-driven accumulation of differentiated cells is due to 
repeated low-grade viral reactivation. Viral reactivation activates CMV-specific T-cells, 
which as a population will both expand (i.e., forming a gradually larger portion of the total 
pool of memory T-cells) and differentiate (i.e., acquire potent cytotoxic capabilities). 
Significantly, there is evidence that psychological and psychosocial stressors, via 
neuroendocrine and immunological pathways, may contribute to this viral reactivation, 
implying that stress exposure may promote this aspect of immunosenescence.  
Herpes infections and latency 
Viruses are microscopic pathogens, consisting of a nucleic acid genome inside a 
protein coat, which can only replicate once inside a living cell. While the immune system 
is able to eradicate most viral infections, some viruses have developed ways to escape this 
fate. The herpes viruses are particularly well-known for this ability to evade immune 
destruction and persist within their human host (Cohrs & Gilden, 2001; Croen, 1991; 
Froberg, 2004; Miller-Kittrell & Sparer, 2009). A characteristic of herpes viruses is that 
they remain dormant in the host, a state denoted as latency, which is interrupted by brief 
periods of reactivation whereby the virus replicates and infects other cells. Herpes viruses 
have been extremely successful in colonizing humans. Their typical infection rates range 
between 30% and 90% of developed countries, depending on the virus, and are, in part, 
related to factors such as age, socioeconomic status, geographical location, sexual 
experience, and early life exposures (e.g., higher infection rates in children that attended 
day care) (Arvin et al., 2007). These viruses employ numerous evasion tactics, such as 
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producing anti-inflammatory IL-10 homologues, in order to avoid immune detection and 
increase survival that can affect immunity (Froberg, 2004). In healthy individual these 
viruses typically elicit mild (e.g., cold sores, fatigue) or no disease symptoms at all. 
However, in immune-suppressed patients (e.g., those with AIDS or using immune 
suppressive drugs), these viruses can elicit very severe complications (Nester et al., 2008). 
Eight herpes viruses have thus far been identified – herpes simplex virus 1 (HSV-1), 
herpes simplex 2 (HSV-2), varizella zoster virus (VZV), Epstein-Barr virus (EBV), 
Roseola virus, T-cell lymphotropic virus, Karposi’s sarcoma-associated herpes virus, and 
finally, CMV, which is the focus of this thesis.   
CMV: epidemiology and pathology 
CMV is a highly prevalent herpes virus; approximately 35% of young children (6-
11 years) and 90% of the elderly (≥80 years) are seropositive (Staras et al., 2006). Overall 
sero-prevalence in western societies approaches 60% (Staras et al., 2006). Individuals free 
from infection at birth will likely become infected early in life: post-natal or childhood 
CMV infection is common, and caused by exchange of bodily fluids, including breast-milk 
(Kenneson & Cannon, 2007; Van Der Meer et al., 1996). An inverse relationship exists 
between socioeconomic status and CMV seropositivity. Though the exact mechanisms are 
unknown, individuals with less education, lower income, and of non-white race are more 
likely to become infected, and at an earlier age, than individuals of a higher socioeconomic 
status (Dowd & Aiello, 2009; Dowd et al., 2009). Studies have also reported differences in 
human CMV infection between various regions within the US and Europe (Bate et al., 
2010; Cannon et al., 2010; Staras et al., 2006). 
As a common, asymptomatic and seemingly innocent infection, CMV has 
consequently not received much public health attention (Wreghitt et al., 2003; Zanghellini 
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et al., 1999). However, this insidious virus may be more damaging than previously 
thought. Cytomegalovirus infection during pregnancy, for example, is now recognized as a 
main cause of infant death and long-term disabilities in the US, and well exceeds that of 
other, better known, congenital conditions such as Down syndrome, fetal alcohol 
syndrome, or spina bifida (Cannon & Davis, 2005; Cheeran et al., 2009). Further, immune-
compromised individuals, such as HIV patients and transplant recipients, can develop life-
threatening complications due to CMV reactivation (Freeman, 2009; Sutherland et al., 
1992). In aging populations, a positive CMV serotatus has been associated with cognitive 
decline, and is implicated in the pathogenesis and severity of cardiovascular diseases 
(Aiello et al., 2006; Söderberg-Nauclér, 2006). In addition, the extent of CMV infection, 
measured by the concentration of immunoglobulin G (IgG) antibodies to CMV, 
independently predicts mortality in older adults (Roberts et al., 2010; Strandberg et al., 
2009). Thus, this once assumed inconsequential virus has a range of deleterious effects, 
particularly within the immune system. The next section will outline these effects, which 
are particularly prominent in CD8+ T lymphocytes. 
The effects of CMV infection on immunity  
As discussed above, one of the hallmarks of an aged immune system is a decline in 
naive (CD27+CD45RA+) CD8+ T-cells and an accumulation of differentiated (CD27− 
CD45RA+/−) CD8+ T-cells. These effects are partly caused by the age-associated 
involution of the thymus. For example, individuals thymectomized in the first few years of 
life exhibit reduced numbers of naive T lymphocytes and increased numbers of late-
differentiated cells (Eysteinsdottir et al., 2004; Sauce et al., 2009; Torfadottir et al., 2006). 
However, it is now clear that CMV is the major driving force behind the accumulation of 
differentiated T-cells (Moss, 2010; Pawelec et al., 2004; Pawelec & Derhovanessian, 2010; 
Pawelec et al., 2009). In particular, the combination of little or no thymic output, a 
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hallmark of aging, and a selective expansion of highly-differentiated, CMV-specific T-cell 
populations leads to a gradual overcrowding by CD8+ T-cells that that have a limited T-
cell repertoire, a process denoted as memory inflation (Akbar & Fletcher, 2005; Brunner et 
al., 2010; Sauce et al., 2009; Van Lier et al., 2003). Remarkably, in some older adults it 
has been observed that up to 70% of the CD8+ T-cell memory pool has become specific 
for CMV epitopes (Appay et al., 2002; Khan et al., 2002), and thus only 30% of the 
memory pool of those individuals is available to combat other antigens. The relation 
between CMV infection and CD8+ T-cell differentiation occurs independent of calendar 
age: young adults infected with CMV similarly exhibit skewing of the T-cell repertoire as 
seen in older adults (Chidrawar et al., 2009; Pita-Lopez et al., 2009; Turner et al., 2014; 
Weinberger et al., 2007). Thus, it seems that infection with this common micro-organism 
accelerates the immunological aging process.  
As noted above, these highly-differentiated CD8+ T-cells are also efficient 
producers of inflammatory cytokines (e.g., TNF- and IFN-,) (Clerici et al., 2001; 
Macaulay et al., 2013; Sansoni et al., 2008; Zanni et al., 2003), which may explain why 
CMV infection and the accumulation of late-differentiated T-cells has been found to be 
associated with increased low-grade inflammation in some studies (Markovic-Plese et al., 
2001; Schmidt et al., 1996; Söderberg-Nauclér, 2006; Sun et al., 2008; Wikby et al., 2006; 
Zanni et al., 2003).  
Together, these effects of CMV on the accumulation of  T-cells with the above 
cluster of characteristics may underlie heightened inflammation, increased risk for 
infection and reduced ability to respond to novel antigens, as well as accelerated cognitive 
decline (Larbi et al., 2009; Saurwein-Teissl et al., 2002; Trzonkowski et al., 2009; Wikby 
et al., 2005). It is perhaps relevant to reiterate here that this cluster of immunological 
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features is also characteristically found in response to protracted psychological stress 
(Segerstrom & Miller, 2004). 
Measuring CMV reactivation 
Most studies that investigated biological markers of CMV reactivation used plasma 
levels of virus-specific IgG as an outcome. This measurement approach is based on the 
assumption that an increased viral load will activate the immune system, thereby 
stimulating B-cells to increase the output of specific antibodies. The validity of the studies 
using antibody titers as an outcome measure appears corroborated by research that used 
other analytical techniques. For example, Kuo et al. (2008) measured CMV viral load 
using real-time quantitative polymerase chain reaction (qPCR) and CMV-specific IgG 
antibody levels among patients undergoing immunosuppressive chemotherapy treatment. 
In most patients, the peak in CMV antibodies was tightly coupled with peak viral loads, 
indicating an active response to CMV replication (Kuo et al., 2008). While there is support 
for the validity of this assumption, mainly from clinical data, it may be relevant to point 
out that other factors may also determine antibody levels. For example, exposure to 
different variants of the same virus, denoted as ‘super-infection’, may generate a more 
extensive polyclonal antibody response and concomitantly higher virus-specific antibody 
levels.  
The number of late-differentiated T-cells is related to viral activity 
One key assumption of the model presented here is that repeated viral reactivation, 
e.g., as a result of stress-induced immune suppression, will promote the accumulation of 
late-differentiated cells and thereby promote the related features of immunosenescence. 
Virus-specific T-cells, such as those targeting CMV, are responsible for preventing 
reactivation and it would therefore be reasonable to assume a direct correlation between 
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the number of those cells and viral load (Ogg et al., 1998; Seckert et al., 2012; Van Baarle 
et al., 2002). Research shows that immune-suppressed individuals (e.g., as a result of 
medical treatment or immunodeficiency diseases) are unable to maintain CMV in latency, 
and show larger expansions of late-differentiated T-cells relative to compared to immune-
competent individuals (Gamadia et al., 2001). Less data is available for healthy free-living 
individuals, and recipients of organ transplants have been frequently used as a model to 
study the kinetic effects of infection and reactivation on T-cell repertoire. CMV-
seronegative patients receiving CMV-infected renal transplants develop primary CMV 
infections, and can therefore be studied longitudinally to examine the effects of CMV 
infection and incessant viral reactivation. Generally, an increase in viral activity (as 
assessed by viral load in plasma, or IgG antibodies to CMV) promotes a compensatory 
increase in the number of CMV-specific T-cells which do not express CD27 or CD28, 
including gamma-delta (γδ) T-cells (Cantisan et al., 2009; Couzi et al., 2009; Gamadia et 
al., 2003; Gamadia et al., 2004). As mentioned above, the selective accumulation of 
EMRA T-cells appears unique to CMV infection, providing a strong empirical basis to 
suggest that these cell populations are reflections of CMV activity (Cantisán et al., 2010; 
Chidrawar et al., 2009; Derhovanessian et al., 2011; Kuijpers et al., 2003; Turner et al., 
2014; Van De Berg et al., 2008; Van Lier et al., 2003). Thus, frequent reactivation of 
CMV, possibly by psychological stress (Coskun et al., 2010; Prosch et al., 2000; Sarid et 
al., 2001), might further exacerbate immunosenescence. The section below will highlight 
the possible mechanisms allowing for CMV reactivation. 
Potential mechanisms of stress-induced CMV reactivation  
The dominant hypothesis in psychoneuroimmunology is that latent viral 
reactivation is due to temporary or persistent stress-induced immune suppression. This 
immune suppression, in turn, may be related to dysregulation (typically hyperactivity) of 
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various neuroendocrine stress systems (Bauer, 2005; Bauer et al., 2000). Best studied in 
this regard are the hypothalamic-pituitary-adrenal cortex (HPA) system, which regulates 
the release of glucocorticoids, and the sympathetic-adrenal-medullary (SAM) nervous 
system, which regulates the release of the catecholamines adrenaline and noradrenaline 
(Glaser & Kiecolt-Glaser, 2005). While there is little doubt that this prototypical psycho-
neuro-immunological pathway plays a role in viral reactivation, more direct pathways may 
be involved as well.  
One example, discussed in more detail here, is direct activation of the CMV 
promoter region by mediators of the stress response. The CMV promoter is a gene segment 
that contains binding sites for transcription factors that are increased during inflammation, 
β-adrenergic stimulation and reactive oxygen species production, and regulates the 
expression of downstream major immediate-early (IE) genes. Expression of these genes 
plays an important role in the initial steps leading to reactivation of CMV from latency 
(Hermiston et al., 1987; Stenberg et al., 1984; Stinski & Isomura, 2008). Thus, stress-
related elevations in these factors may directly trigger CMV to reactivate. Systemic 
inflammation, particularly TNF-α, has been associated with CMV reactivation in various 
patient groups, including cardiovascular, transplant patients (Humar et al., 1999; Tong et 
al., 2001; Widmann et al., 2008) and intensive care unit (ICU) patients (Chilet et al., 2010; 
Limaye & Boeckh, 2010; Limaye et al., 2008). Experimental evidence demonstrates that 
elevated sympathetic activation, and the concomitant release of the catecholamines, 
adrenaline and noradrenaline, are likewise capable of inducing CMV reactivation in these 
cells, as measured by expression of the IE gene (Docke et al., 1994; Montminy, 1997; 
Prosch et al., 1999; Prosch et al., 2000; Stein, Volk, Liebenthal, Kruger, et al., 1993). In 
addition, stress-induced elevations in blood glucose and other metabolic factors can result 
in the production of reactive oxygen species (Cohen et al., 2011; Epel, 2009), which have 
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been shown to cause an up to 3-fold increase in promoter activation in vitro (Jaganjac et 
al., 2010). These findings represent important non-immunological pathways by which 
stress may cause CMV reaction. It should be noted that although expression of the IE 
genes are a first and essential step in reactivation, it is not sufficient for full viral 
replication, and therefore the definitive evidence for this mechanism still needs to be 
established. 
Summary of the current literature  
While much research effort has been dedicated to identifying the biological 
determinants of immunosenescence, the potential role of psychosocial and behavioral 
factors remains ill-considered. This neglect seems unwarranted considering the remarkable 
similarities between the functional and phenotypical immune changes observed during 
immunosenescence and those seen in response to protracted psychosocial stress. These 
changes include increases in circulating EM and EMRA CTLs, impaired proliferation in 
response to mitogens, shortening of telomeres, diminished response to vaccination, and a 
skewed CD4:CD8 ratio. These parallels beg the question of whether the overlapping age- 
and stress-related immune effects involve similar pathways. The next section will address 
the evidence for how specific psychosocial and behavioral factors may activate these 
mechanisms and thereby promote CMV reactivation. 
Psychosocial and behavioral factors and CMV reactivation 
There is compelling evidence that links between psychosocial and behavioral 
factors and immunosenescence may share CMV as a common pathway. Particularly, 
psychological stress, personality, physical activity and glucose metabolism have received 
much research attention, and the results show remarkably consistent associations between 
these factors, health and longevity (Barr et al., 2009; Chapman et al., 2011; Woodcock et 
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al., 2011). Each of these factors may also enhance or reduce CMV infection and/or its 
reactivation. It is this interaction with CMV activity that may tie these seemingly unrelated 
factors together and underlie their individual associations with the acceleration, delay or 
possible mitigation of various aspects of immunosenescence (see Figure 1.1). Below, I will 
briefly introduce the factors explored in this thesis and describe the current evidence 
linking each to CMV infection and/or reactivation. 
 
Figure 1.1: Psychosocial and behavioral factors share CMV and its reactivation as a 
pathway to immunosenescence 
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Psychological stress  
The stress literature has utilized a wide variety of stressor models, such as elevated 
anxiety and depressive symptoms (Phillips et al., 2008), academic exams (Bosch et al., 
2001; Bosch et al., 2003), Alzheimer caregiving (Glaser & Kiecolt-Glaser, 2005), space 
flight (Mehta et al., 2000), and post-traumatic distress disorder (PTSD) (Gill et al., 2009). 
Table 1.1 and 1.2 below summarize findings from studies associating these various 
measures of psychological stress and CMV reactivation. The results of these studies paint 
a fairly consistent picture whereby higher levels of distress are associated with more CMV 
reactivation. This association is in line with what has been found in studies on other herpes 
viruses such as Epstein-Barr virus (EBV) and herpes simplex virus type 1 (HSV-1), which 
likewise show increased antibody titers with higher stress (Esterling et al., 1993; Mcdade 
et al., 2000; Shirtcliff et al., 2009). Taken together, these studies provide preliminary 
evidence for an association between psychological stress and CMV reactivation; however 
further investigation of these associations in larger, non-clinical and/or working-aged 
populations is warranted. 
  
  
Table 1.1: Psychological stress and CMV reactivation studies. 
Study Population N 
Measure of 
Stress 
Measure of  
CMV 
reactivation 
Main Finding 
Appels et al. (2000) Coronary artery 
disease patients  
30 Depressive 
symptoms and 
vital exhaustiona  
CMV antibody 
titers 
Patients classified as exhausted (N=15) showed 
elevated CMV titers compared to non-exhausted 
patients 
Bennett et al. (2012) Older adults (64 
yrs) 
222 Depressive 
symptoms  
CMV antibody 
titers 
CMV antibody titers were not related to CES-D scores; 
however, for the EBV+CMV+ group, higher EBV 
antibody titers were related to higher CES-D scores, but 
not for the EBV+CMV- group  
Fagundes et al. 
(2012) 
Newly-diagnosed 
breast cancer 
patients (57 yrs) 
158 Fatigue and 
depressive 
symptoms 
CMV antibody 
titers 
Higher CMV antibody titers were associated with a 
greater likelihood of being fatigued, but not depressive 
symptoms 
Glaser et al. (1985) First-year 
medical students 
20 Academic 
examinations 
CMV antibody 
titers 
Found a significant increase in levels of CMV titers 
during the first day of exams as compared to a non-
stress baseline (the end of summer vacation) 
Jaremka et al. 
(2013) 
Breast  cancer  
survivors (51 yr) 
200 Loneliness, 
depression, 
fatigue and pain 
CMV antibody 
titers 
Higher CMV antibody titers were associated with 
higher loneliness and levels of the symptom cluster 
(pain, depression, and fatigue) 
Matalka et al. (2000) CMV-positive 
female nursing 
students 
12 Academic 
examinations 
Defined as a 30% 
increase in virus-
specific IgG 
levels in sera 
Found CMV reactivation in 26% (N=12) of students 
during exams in both semesters; larger  stress effects on 
CMV reactivation were found during the winter season 
a Vital exhaustion: a constellation of symptoms characterized by listlessness and fatigue 
  
  
Table 1.2: Psychological stress and CMV reactivation studies  (continued) 
Study Population N 
Measure of 
Stress 
Measure of  
CMV 
reactivation 
Main Finding 
Mehta et al. (2000) Astronauts  71 Space flight 
stress 
Number of viral 
particles in urine 
using qPCRb and 
antibody titers 
10.2% of the astronauts shed viral particles in urine 
samples around the time of their mission, compared to 
1.2% of controls; among shedders, CMV IgG 
antibody titer increased from pre- to post-flight 
Phillips et al. (2008) Older adults 
(65+ yrs) 
137 Anxiety & 
depression 
symptoms 
CMV antibody 
titers 
Higher CMV antibody was associated with higher 
depressive symptoms, anxiety and overall psycho 
morbidity 
Sarid et al. (2004) First-year 
nursing and 
physiotherapy 
students  
54 Academic 
examinations 
CMV-specific 
salivary IgG and 
IgA antibody 
Found an approximate 65% increase in CMV-specific 
salivary IgG and a 46% increase in CMV-specific 
salivary IgA, compared to the beginning of the 
semester 
Toro & Ossa (1996) Healthy CMV-
positive 
individuals 
11 Stressful 
psychological 
and physical 
eventsc 
CMV DNA by 
qPCR in blood, 
throat washings 
and urine 
Found a positive association between CMV DNA and 
stress-producing events in the workplace over a 6-
month period 
Trzonkowski et al. 
(2004) 
Patients with 
depression and 
controls 
20 Depression CMV antibody 
titers 
Patients suffering from depression (N=10) had higher 
levels of CMV antibody, compared to healthy 
controls 
 Uddin et al. (2010) Participants of 
the Detroit 
Neighborhood 
Health Study  
100 Post-traumatic 
stress disorder 
(PTSD)d 
CMV antibody 
titers 
Those with PTSD (N=23) had an approximately 45% 
higher level of CMV-specific IgG antibody compared 
to unaffected individuals 
b qPCR: quantitative polymerase chain reaction; c Stressful events: physical trauma, surgery, X-ray or UV radiation exposure; 
academic tasks, work overload, insomnia;  d PTSD: a severe anxiety disorder that can develop after exposure to a psychologically 
impactful event, like being a victim of crime, accident, or a disaster or being a close witness to such events 
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In addition to CMV reactivation, psychological stress may also impact the prevalence 
of CMV infection, although the evidence in this regard is mixed. For example, Miller and 
colleagues (2005) investigated the association between serostatus and depressive symptoms in 
sample of 65 patients recovering from an acute coronary syndrome. After splitting the subjects 
into three equal groups based on depression scores (using the Hamilton Rating Scale for 
Depression and Beck Depression Inventory), cardiac patients in the highest depression tertile 
were more likely to be CMV seropositive than the middle and lower tertiles. However, 
Phillips et al. (2008) found no association between CMV serostatus and depression and 
anxiety symptoms in 137 older adults.  
Personality 
Personality has been described as a characteristic manner in which one feels, thinks, 
behaves, and relates to others. As such, personality represents a powerful summary construct 
that encompasses the biological, experiential, and social aspects of an individual. Unlike other 
psychological constructs, such as mood or cognition, these characteristics are stable over time 
and, thus, reliably predict many aspects of health and longevity (reviewed in Chapman et al., 
2011). Several models have been proposed to explain these links between personality and 
disease; however, many of these models have not been commonly tested (reviewed in Smith 
& Mackenzie, 2006). Despite the clear evidence for these associations, the underlying 
pathways remain to be elucidated. 
Certain personality traits not only lead to increased occurrence of stressors, but can 
also affect the reactivity to stressors (Segerstrom, 2000). For example, Bolger and Schilling 
(1991) found that those high in neuroticism reported more exposures to daily stressors and 
experienced more distress from these situations, compared to those with low neuroticism. 
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Epidemiological data has, indeed, associated high levels of neuroticism with elevated evening 
levels of cortisol among subjects aged <75 years (Gerritsen et al., 2009), suggesting HPA-axis 
dysregulation in these individuals. This enhanced stress reactivity may form a basis for more 
frequent CMV reactivation among these individuals via the neuroendocrine pathways 
described above. Also, less well-considered is that personality also dictates several enduring 
behavioral features which may increase exposure to infectious disease, including sexual 
behaviors and social contacts (Asendorpf & Wilpers, 1998; Hoyle et al., 2000). The 
implication here is that stable personality traits could systematically predispose certain 
individuals to not only immune suppression, but also to more opportunities for infection. 
Thus, personality may be particularly relevant in the context of stress and immunosenescence. 
Physical activity 
Physical activity is simply defined as any body movement produced by skeletal 
muscular action that increases energy expenditure. Included under this umbrella term are more 
purposeful categories of movement, including sports, exercise and occupational and 
household activities (Caspersen et al., 1985). Meta-analyses have shown dose-response 
relationships of physical activity with 19% to 24% reductions in all-cause mortality rates for 
more active individuals (Woodcock et al., 2011). A physically active lifestyle is associated 
with a wide range of both physical and mental health benefits. How physical activity affects 
immune function and the risk of infection, however, remains under debate (Gleeson et al. 
2012; Romeo et al., 2010; Walsh et al., 2011).  
There is a strong contention that regular exercise can delay or even reverse features of 
immunosenescence (Drela et al., 2004; Kohut & Senchina, 2004; Simpson et al., 2012). For 
example, moderate intensity exercise training in mice has resulted in reduced numbers of 
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memory T-cells  (Woods et al., 2003), while telomere-stabilizing proteins are elevated in 
trained mice, and humans, compared to their untrained counterparts (Werner et al., 2009). 
Importantly, increased aerobic fitness was associated with lower proportions of highly-
differentiated T-cells in men (Spielmann et al., 2011). This association was unaffected by 
CMV infection status, implying that frequent exercise may counteract immunosenescence 
irrespective of infection with this immune-dominant virus. This finding may result from 
selective mobilization of highly-differentiated cells, including CMV-specific T-cells, into 
circulation with exercise, possibly leading to their subsequent deletion (Simpson, 2011). 
However, in longitudinal studies, these types of immune benefits accompanying 
improved fitness are inconsistent at best. The variation in study designs (e.g., modes, 
durations, and intensities) employed by different researchers may be confounding the effect of 
physical activity in these studies (Simpson et al., 2012). There are hints that longer training 
regimens show more consistent immune effects, and combined with the larger fitness gap 
covered in cross-sectional studies, this observation suggests that the volume of participation in 
physical activity, in general, may enhance immunity later in life (Simpson & Bosch, 2014). It 
should also be considered that too much exercise (or other stressors) in early life (childhood to 
mid-twenties) may be detrimental to immunity later in life (Prieto-Hinojosa et al., 2014). 
Altogether, it appears that physical activity may improve immune functioning and resistance 
to infection by directly combating features of immunosenescence, such as the accumulation of 
highly-differentiated T-cells. This assumption is predicated on a long-term commitment to 
physical activity, which has not been examined in the context of T-cell differentiation to date. 
 20 
 
Glucose metabolism 
Metabolism, as referred to here, is the tightly regulated process of cellular utilization 
of bodily nutrients which provides energy. During the immune response to infection, large 
amounts of resources and energy (e.g., cell division, temperature elevation, cytokine 
production) are mobilized to effectively deal with the threat (Ganeshan & Chawla, 2014; 
Maciver et al., 2008; Pearce, 2010). A similar response is elicited for both physical and 
psychological threats, whereby anticipation of ‘fight or flight’, and potential bodily insult, 
results in the release of glucose and other metabolites into circulation. Glycated hemoglobin 
(HbA1c) is a long-term marker which captures the average circulating glucose levels over the 
previous 3-4 months in a single measurement (Peterson et al., 1998). Glucose metabolism is 
influenced by multiple behavioral factors, and, as such, elevated HbA1c levels have been 
associated with increased psychological stress (Schuck, 1998), certain personality types (Lane 
et al., 2000; Vollrath et al., 2007; Waller et al., 2013) and decreased physical activity 
(Umpierre et al., 2011). 
In the very elderly (85 years old), elevated levels of HbA1c, fasting glucose and an 
increased prevalence of type-2 diabetes have been found among CMV+ individuals, compared 
to those CMV– (Chen et al., 2012). This elevated level of glucose may be a cause or 
consequence of CMV infection and/or reactivation. Dysregulation of glycemic control (e.g., 
chronic psychological stress and HPA-axis activation) can result in inappropriately elevated 
circulating glucose levels and increased production of reactive oxygen species (Cohen et al., 
2011; Epel, 2009). This oxidative stress not only suppresses immunity, but its downstream by-
products also may directly trigger CMV reactivation (Jaganjac et al., 2010; Muriach et al., 
2008). So, whether considered independently, or in combination with CMV, chronically 
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elevated levels of glucose are associated with multiple features reminiscent of 
immunosenescence, including shorter telomere length and increased T-cell accumulation 
(Adaikalakoteswari et al., 2007; Maciver et al., 2008; Zhao et al., 2007). These hallmarks can 
even be seen at earlier stages of hyperglycemia and impaired glucose tolerance 
(Adaikalakoteswari et al., 2007; Salpea & Humphries, 2010) and are evident in poorer control 
and increased severity of infection in diabetic individuals (Allard et al., 2010; Joshi et al., 
1999). 
Conversely, CMV is known to hijack its host’s metabolism to create an environment 
conducive to increased viral replication. Insulin-producing β-cells of the pancreas are 
permissive to CMV infection. Once infected, the resultant immunogenicity, ensuing 
inflammation and β-cell destruction may lead to decreased insulin production, thus elevating 
glucose levels and suppressing immunity (Smelt et al., 2012). It is possible that this CMV 
manipulation and the abovementioned oxidative stress synergize to accelerate the 
accumulation of highly-differentiated T-cells; however, the association between glycemic 
control and the accumulation of these cells has not been investigated directly. 
Conclusion and the aim of this thesis 
Herein is presented a model whereby infection history, particularly latent infection 
with and reactivation of CMV, is a putative shared mechanism linking psychosocial and 
behavioral factors and the age-related decline in immunity. Specifically, it is hypothesized that 
CMV may act as a mediator between psychological stress, personality, physical activity and 
glucose metabolism and immunosenescence (Figure 1.1). Thus, the aim of this thesis is to 
explore the validity of this hypothesis in a large sample of working-aged adults. Chapter 3 
explores the association of multiple measures of psychological stress and the reactivation of 
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CMV, measured as levels of CMV-IgG antibody. Chapter 4 explores the influence of 
personality traits on CMV infection prevalence and CMV-IgG levels. Chapter 5 investigates 
the impact of physical activity frequency on the age-related accumulation of highly-
differentiated T-cells, and the effects of CMV infection on these relationships. Chapter 6 
explores the role of dysregulated glucose metabolism in the accumulation of highly-
differentiated T-cells.  
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CHAPTER 2 : GENERAL METHODS 
Study samples 
The Mannheim Institute of Public Health (MIPH) Industrial Cohort Studies (MICS) 
perform voluntary health checks on the employees of an airplane manufacturing company in 
the south of Germany. Participants included in this thesis are from two separate sub-samples 
of the 2007 and 2011 collections. Only participants who gave informed consent were included 
in this thesis. There were no specific inclusion/exclusion criteria for participation in the health 
check. Questionnaire and physical examination data was available for N=910 and N=1454 
individuals from 2007 and 2011, respectively. From 2007, N=887 (97%) of the subjects had 
plasma samples available for CMV antibody determination and were included in the analyses. 
From the 2011 collection, N=1103 (76%) of the subjects had a complete set immune data 
measured and were included in analyses. The participant characteristics are presented in Table 
2.1. On average, participants were predominantly males in their early- to mid-forties. They 
were mostly married, non-managerial skilled workers, right below the upper limit for normal 
BMI and waist-to-hip ratio. Approximately one-fourth were current smokers, smoking less 
than a pack per day.  
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Table 2.1 Participant characteristics - MICS 2007 and 2011 
 2007 2011 
N 887 1103 
CMV positive (%) 37 36 
Age (years) 44.7 ± 10.1 40.1 ± 11.0 
Gender (% male) 88 88 
Married/Co-habitating (% yes) 70 77 
Job status (%) -- -- 
     Division/Dept manager 4 4 
     Project Leader/process mgr 19 15 
     Skilled worker (non-mgr) 71 72 
     Semi-skilled worker 6 9 
Current smoker (% yes) 26 29 
Cigarettes per day (in smokers) 13 ± 12 14 ± 8 
Body mass index (kg/m2) 24.5 ± 3.5 24.5 ± 4.0 
Waist-to-hip ratio 0.92 ± 0.07 0.90 ± 0.08 
 Values are mean ± SD unless otherwise specified 
 
Measurements1 
The questionnaire and physical examination collection were performed by 
HealthVision Ltd. (Berlingen, Switzerland), subsequent biochemical analyses on collected 
samples were completed by SynLab (Leinfelden, Germany) and all the data for this thesis was 
provided via the MIPH. The set of measurements differed slightly between the two 
collections; thus, some variables were included in 2007, but not in 2011, and vice versa. The 
variables available from each respective collection are listed in Table 2.2. The most notable 
distinction lies in the CMV and T-cell differentiation data. In both samples, CMV serostatus 
(i.e., infection/not infected) was available. In the 2007 sample, I further analyzed continuous 
levels of CMV-specific antibodies. In the 2011 sample, I collected the immunological data for 
                                                 
1 Parts of this general methods section are written in the first person to indicate where work was conducted by J. 
L. Rector rather than using pre-existing data from the rest of the epidemiological study 
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T-cell differentiation determination, but due to limited financial resources, was not able to 
further analyze plasma samples for CMV antibodies (see description below). The data 
presented in chapters 3 and 4 were drawn from the MICS 2007 dataset using CMV-IgG 
antibody levels as a measure of CMV reactivation. The data presented in chapters 5 and 6 
were drawn from the MICS 2011 dataset using the accumulation of highly-differentiated T-
cells as a measure of immunosenescence.  
Table 2.2: Variable availability in the 2007 and 2011 MICS datasets 
Variable 2007 2011 Variable 2007 2011 
Demographic Psychological variables 
Age   Anxiety (HADS)   
Gender   Depression (HADS)   
Marital status   Vital exhaustion(MQ)   
Subjective mental health (SF-12)   
Socioeconomic 
Education   Metabolic factors 
Job status   HbA1c   
Income   Fasting glucose non-fasting  
Manual occupation   Total cholesterol   
Shift worker   Low density lipoprotein (LDL)   
High density lipoprotein (HDL)   
Lifestyle Triglycerides   
Current smoking   
Cigarettes per day   Biological factors 
Alcohol intake continuous categorical C-reactive protein (hs-CRP)   
Body mass index   Fibrinogen   
Waist-to-hip ratio   Metabolic syndrome   
Waist circumference   Resting heart rate   
Physical activity (kcal/day)   Blood pressure   
Leisure activity (h/wk)   
Immune parameters 
Big 5 personality traits   T-cell phenotypes   
CMV status   
Physical activity frequency   CMV-specific antibodies (IgG)   
  = available;  = unavailable; Further details for each variable is available in the relevant methods 
sections of the chapters in this thesis. 
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Cytomegalovirus (IgG) serostatus determination 
For both the 2007 and 2011 samples (N=2,341 total), fasting plasma samples were 
stored in small aliquots at -80°C until analysis. Evidence of previous CMV infection 
(serostatus) was determined using a commercially available enzyme-linked immunosorbent 
assay (ELISA) (BioCheck, Inc., CA, USA) according to manufacturer instructions. Optical 
density values obtained from participant samples were fitted to a standard curve. These 
concentrations were then compared to a cut-off value to compute CMV index scores. 
Participants with a borderline seropositive result, representing a calculated index score >0.85 
and <1.15, were retested (N=16 in 2007; N=9 in 2011). If they remained borderline, subjects 
with index scores above and below 1.00 were considered positive (CMV+) and negative 
(CMV–) respectively, as per manufacturer instructions. The sensitivity, specificity, and 
accuracy of the test are reported as 95.0, 96.7 and 96.0%, respectively.  
For the 2007 subjects only, I further analyzed the plasma samples for continuous levels 
of CMV-IgG among those infected. Because the BioCheck assay is not recommended for 
quantitative determination of antibody levels, I measured CMV-IgG with a commercially 
available ELISA kit (Genesis Diagnostics Ltd., Cambridgeshire, UK) according to the 
manufacturer’s instructions. The manufacturer’s reported within-assay and between assay 
imprecision was <12%. Like the BioCheck assay, each subject was assayed in duplicate and 
the scores averaged to yield the final antibody concentration. These concentrations were used 
in subsequent analyses.  
Flow cytometry 
During the 2011 collection only, I prepared the subject samples, on-site, for T-cell 
phenotyping by flow cytometry. Whole blood samples were collected by trained nurses in 
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ethylenediaminetetraacetic acid (EDTA) coated tubes (Sarstedt, Nümbrecht, Germany). These 
samples were stored at room temperature and I prepared them within 1 hour of collection. 
Upon receiving the sample, I stained 30 μL of the whole blood with a combination of the 
following monoclonal antibodies: CD3 APC-Cy7, CD4 PerCP, γδTCR PE, CD8 APC, (BD 
Biosciences, San José, CA), CD45RA FITC, and CD27 PE-Cy7 (BD Pharmingen, San Diego, 
CA). Following 20 minutes of incubation at room temperature in the dark, I added 1.5 mL of 
BD FACS lysing solution was to the mixture, which was incubated for another 15 minutes. 
After a 7-minute centrifugation at 700xg, I removed the supernatant and re-suspended the 
pellet in 250 µL of 2% paraformaldehyde solution until analysis. Data was collected using a 
FACSCanto II flow cytometer (BD Biosciences, San José, CA) and the FACS Diva software 
(BD Biosciences, San José, CA) with at least 10,000 gated lymphocyte events collected for 
each tube. The cytometer was regularly calibrated by laboratory personnel. Spectral overlap 
was electronically compensated for using single labelled antibody tubes.  
Following acquisition, FCS files were transferred to a third party software program 
(FlowJo v7.6.5, Tree Star, Inc., Ashland, OR) for analysis. Figure 2.1 shows representative 
plots of the gating strategy employed for each subject file. Briefly, gated CD3+ (T-
lymphocytes) were stratified by γδTCR expression. Both subsets of CD3+ T-cells, i.e., 
γδTCR+ and γδTCR– (referred to from here on simply as CD3+ T-cells), were further 
subdivided by their expression of CD4 and CD8. Single-positive CD8+ T-cells (cytotoxic T 
lymphocytes; CTL) were then split into stages of differentiation based on their CD27 and 
CD45RA expression. CD27+CD45RA+ were naive (NA), CD27+CD45RA– were central 
memory (CM), CD27–CD45RA– were effector memory (EM), and CD27–CD45RA+ were 
CD45RA re-expressing effector memory (EMRA). The same CD27/CD45RA classification 
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was made with γδTCR+ T-cells. These percentages were multiplied by absolute numbers of 
lymphocytes to obtain cell numbers. The γδTCR+ subset were predominantly CD4 and CD8 
double-negative or CD8 single-positive, and because of their low frequency in peripheral 
blood, these subsets were added together and simply analyzed as total NA, CM, EM, and 
EMRA γδTCR+ T-cells. 
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Figure 2.1:Sample gating strategy to derive T-cell subsets. 
Lymph, lymphocytes; CD, cluster of differentiation; TCRgd, gamma-delta (γδ) T-cell 
receptor; Th, CD4+ helper T-cell; Tc, CD8+ cytotoxic T-cell; DP, double-positive CD4/CD8; 
DN, double-negative CD4/CD8; NA, naive; CM, central memory; EM, effector memory; 
EMRA, CD45RA+ effector memory. 
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Data collection and analyses 
The MIPH sent the 2007 samples to the University of Birmingham, where I 
independently completed the BioCheck and Genesis CMV IgG antibody ELISA analyses in 
the Behavioral Immunology laboratory.  
I set up and worked in the on-site laboratory for the 2011 collection in Augsburg, 
Germany. The above-described preparation of participant samples for flow cytometry, and the 
collection of plasma for later CMV serological testing, were carried out by an on-site 
laboratory assistant (S. Stark) and I. The daily collection of flow cytometry data was carried 
out by two laboratory assistants at the MIPH (I. Gregei & T. Rausch) and me. After the 
collection, the frozen plasma samples were sent from the MIPH to the University of 
Birmingham, where I carried out the ELISA analyses with the laboratory assistance of L. 
Rotar. Ms. Rotar also assisted with the analysis of the flow cytometry data. 
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CHAPTER 3 : CONSISTENT 
ASSOCIATIONS BETWEEN MEASURES 
OF PSYCHOLOGICAL STRESS AND 
CMV ANTIBODY LEVELS IN A LARGE 
OCCUPATIONAL SAMPLE 
Abstract 
Cytomegalovirus (CMV) is a herpes virus that has been implicated in biological aging 
and impaired health. Evidence, largely accrued from small-scale studies involving select 
populations, suggests that stress may promote non-clinical reactivation of this virus. However, 
absent is evidence from larger studies, which allow better statistical adjustment for 
confounding and mediating factors, in more representative samples.  
The present study involved a large occupational cohort (n=887, mean age=44, 88% 
male). Questionnaires assessed psychological (i.e., depression, anxiety, vital exhaustion, SF-
12 mental health), demographic, socioeconomic (SES), and lifestyle variables. Plasma 
samples were analyzed for both the presence and level of CMV-specific IgG antibodies 
(CMV-IgG), used as markers for infection status and viral reactivation, respectively. Also 
assessed were potential biological mediators of stress-induced reactivation, such as 
inflammation (C-reactive protein) and HPA function (awakening and diurnal cortisol). 
Predictors of CMV infection and CMV-IgG among the infected individuals were analyzed 
using logistic and linear regression analyses, respectively.  
Confirming prior reports, lower SES (education and job status) was positively 
associated with infection status. Among those infected (N=329), higher CMV-IgG were 
associated with increased anxiety (β=.14, p<.05), depression (β=.11, p=.06), vital exhaustion 
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(β=.14, p<.05), and decreased SF-12 mental health (β=–.14, p<.05), adjusting for a range of 
potential confounders. Exploratory analyses showed that these associations were generally 
stronger in low SES individuals. We found no evidence that elevated inflammation or HPA-
function mediated any of the associations.  
In the largest study to date, we established associations between CMV-IgG levels and 
multiple indicators of psychological stress. These results demonstrate the robustness of prior 
findings, and extend these to a general working population. We propose that stress-induced 
CMV replication warrants further research as a psychobiological mechanism linking stress, 
aging and health.  
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Introduction 
There is convincing evidence that psychological stress impacts health, with the 
immune system likely playing an important mediating role (Miller et al., 2009; Segerstrom & 
Miller, 2004). An elegant in vivo paradigm to study the impact of stress on the immune system 
is the reactivation of latent herpes viruses, such as herpes simplex virus (HSV), Epstein-Barr 
virus (EBV), varicella zoster virus (VZV), or cytomegalovirus (CMV) (Glaser & Kiecolt-
Glaser, 1997; Glaser & Kiecolt-Glaser, 2005). These infections are distinctive because the 
host is unable to completely eliminate the virus, establishing a life-long competition between 
the pathogen and the host immune system (Sinclair, 2008). In immune competent individuals, 
the virus mostly remains in a dormant (i.e., low-replicating) state, denoted as latency. 
However, when immune control is weakened, the virus begins to replicate, which in turn 
stimulates memory B lymphocytes to increase the output of virus-specific IgG antibody. This 
increase results in the seemingly paradoxical observation that higher antibody levels reflects 
poorer immune control of the virus (Glaser & Kiecolt-Glaser, 1994; Kuo et al., 2008; Van 
Zanten et al., 1995).  
The current study focused on psychosocial factors related to CMV infection status and 
CMV-IgG levels (reflecting reactivation of the virus). CMV is a highly prevalent β-herpes 
virus which asymptomatically infects between 30% and 90% of the population in developed 
countries (Staras et al., 2006). Prevalence of CMV increases nearly linearly with age (Crough 
& Khanna, 2009; Staras et al., 2006) and with lower socioeconomic status (SES) (Dowd et al., 
2009; Enders et al., 2012; Mustakangas et al., 2000; Simanek et al., 2009). CMV has long 
been considered harmless to healthy immune competent hosts. More recently, this consensus 
has been revised on the basis of studies that have associated this virus with increased 
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mortality, especially among older adults (Gkrania-Klotsas et al., 2012; Pawelec et al., 2012; 
Simanek et al., 2011; Strandberg et al., 2009). These epidemiological findings are 
complemented by studies showing correlations between CMV infection and poor health 
outcomes, such as the development of metabolic and cardiovascular diseases (Cheng et al., 
2009; Haarala et al., 2012; Hjelmesaeth et al., 2004; Nabipour et al., 2006), autoimmune 
disease (Söderberg-Nauclér, 2012; Varani & Landini, 2011) some cancers (Dziurzynski et al., 
2012; Michaelis et al., 2009), as well as cognitive decline and poor functional status (Aiello et 
al., 2006; Gow et al., 2013; Moro-Garcia et al., 2012).  
One prominent explanation for these health effects pertains to the possible role of 
CMV in accelerating aging of the immune system, a process denoted as immunosenescence 
(Pawelec et al., 2009; Turner et al., 2014). Indeed, studies show that CMV infection and 
CMV-IgG levels are associated with markers of impaired immunity that characterize aging. 
These include impaired vaccination responses (Mcelhaney et al., 2012; Turner et al., 2014), 
increased inflammation (Freeman, 2009; Qiu et al., 2008), selective accumulation of T-
lymphocytes with impaired responsiveness to mitogens (Chidrawar et al., 2009), reduced 
telomere length (Van De Berg et al., 2010), and reduced telomerase activity (Dowd et al., 
2013). Together these findings suggest that research identifying factors that predict CMV 
infection status and reactivation may significantly contribute to understanding the 
determinants of healthy aging (Nikolich-Zugich, 2008). 
Psychological stress has been identified as one of the factors that can drive subclinical 
CMV replication, representing a potential mechanism linking stress, immunity and aging 
(Bosch et al., 2012). In one of the earliest studies, Lycke et al. (1974) found that hospital 
psychiatric patients had higher CMV-IgG than healthy controls. Subsequent confirmations 
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were provided by naturalistic stress studies involving caregiving (Pariante et al., 1997), 
spaceflight (Mehta et al., 2000), academic exams (Glaser et al., 1985; Matalka et al., 2000; 
Sarid et al., 2004), post-traumatic stress disorder (PTSD) (Uddin et al., 2010), and childhood 
adversity (Dowd et al., 2012; Fagundes et al., 2013). Studies assessing self-reported stress 
confirmed these associations, and helped to further characterize the psychological variables 
involved. For example, studies in older adults identified depression and anxiety as factors 
associated with higher CMV-IgG (Phillips et al., 2008; Trzonkowski et al., 2004). In a cohort 
of cardiovascular patients, Appels, Bär, et al. (2000) found higher CMV antibody levels 
among those reporting vital exhaustion (VE), a state characterized by lack of energy, 
increased irritability, and feelings of demoralization (Appels, Kop, et al., 2000; Appels & 
Mulder, 1988). Related, higher levels of fatigue were associated with higher CMV-IgG in 
breast cancer patients (Fagundes et al., 2012).  
Despite apparently consistent associations between stress and CMV reactivation, the 
interpretation of these findings is hampered by some limitations. First, many of the 
aforementioned studies allowed only limited statistical adjustments due to very small sample 
sizes2. This leaves ambiguity with regard to the proper interpretation of these findings (e.g., 
potential confounding). A second limitation is that prior reports involved samples drawn from 
select populations, like patient groups, astronauts, or older adults, which creates uncertainty 
with regards to the generalizability of the findings. To determine the robustness and 
generalizability of the observed associations between psychological factors and impaired viral 
control, research in larger and more representative populations would be needed (Dowd et al., 
2008).  
                                                 
2 To date only 4 studies had an N>50, two of which involved cancer patients or survivors (Fagundes et 
al. 2012; Jaremka et al. 2012) two studied older adults (Bennett et al. 2012; Phillips et al. 2008). 
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A further limitation of the extant literature is that little attention has been paid to 
possible intermediate mechanisms. For example, experimental studies show that inflammatory 
mediators (Döcke et al., 1994; Fagundes et al., 2012; Stein, Volk, Liebenthal, Krüger, et al., 
1993) and glucocorticoids (Lathey & Spector, 1991; Tanaka, Ogura, Kamiya, Sato, et al., 
1984) can promote CMV reactivation. As these factors may also become elevated in response 
to psychological stress, these represent indirect pathways linking stress and CMV reactivation 
(cf. Fagundes et al., 2012). In order to address these limitations, the present study investigated 
associations between CMV reactivation, anxiety, depression, and vital exhaustion in a large 
sample of working adults. Analyses involved adjustment for demographic factors and health 
behaviors, and also tested if inflammation and HPA activity may act as possible mediators. 
Informed by prior research showing a larger impact of stress in low-SES individuals (Brydon 
et al., 2004; Gruenewald et al., 2006), we also performed exploratory analyses to determine if 
associations between psychological predictors and CMV-IgG may vary by SES group.  
Materials and Methods  
Participants 
The present study was conducted in a cross-sectional sample of the Mannheim 
Institute of Public Health Industrial Cohort Studies (MICS), consisting of 887 employees who 
took part in a voluntary company health check (Herr et al., 2012; Li et al., 2013). Participant 
characteristics are presented in Table 3.1. Participants received a personalized health report. 
All data was anonymized before analysis. The study was approved by the Ethical Committee 
of the Mannheim Medical Faculty, Heidelberg University, and all participants signed 
informed consent. 
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Procedures 
Participants arrived in the morning between 06:45h and 08:45h for assessment. After a 
fasting blood draw, participants were seated separately in a quiet room to fill out 
questionnaires at a location away from their usual workplace. Demographic, medical, and 
health behavior data were assessed by questionnaire, anthropometric measurements (e.g., 
height, weight, waist and hip circumference) and blood pressure were determined by trained 
personnel, using standard procedures. 
Psychological questionnaires and quality of life 
Anxiety and depression were assessed using the Hospital Anxiety and Depression 
Scale (HADS) (Zigmond & Snaith, 1983), which is commonly used in general population 
studies (Crawford et al., 2001; Mykletun et al., 2001). The anxiety and depression subscales 
comprise 7 items using a 4-point Likert scale format (Cronbach’s α of .81 and .82, 
respectively). The 9-item Shortened Maastricht Exhaustion Questionnaire (MQ) measured 
vital exhaustion (VE), which is reflective of lack of energy, increased irritability, and feelings 
of demoralization (Kopp et al., 1998). Higher scores indicate increased vital exhaustion 
(Cronbach’s α=.91). The 12-item Health Survey (SF-12), version 2, evaluated subjective 
quality of life on two dimensions – physical and mental health. For the purpose of this study 
only the latter subscale was analyzed. Higher scores (range 0-100) indicate better well-being 
(Ware et al., 1996). Sleep quality was measured by the Jenkins Sleep Problems Scale (Jenkins 
et al., 1988), which assessed the frequency of four common sleep disturbances (6-point Likert 
scale) within the last month (ranging from “not all” to “22-31 nights”), including trouble 
falling asleep, waking up at night, trouble staying asleep, and waking feeling tired and worn 
out (Cronbach’s α=.79).  
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Socio-demographic and lifestyle data 
Demographic data (e.g., age, gender, and marital status), SES indicators (job status, 
education level, and net monthly income), and health behaviors (e.g., smoking, alcohol, 
physical activity, and diet) were obtained by questionnaires previously validated in the 
MONICA study (Jönsson et al., 1999). Participants were identified as current smokers by self-
report and smoking frequency was assessed as the number of cigarettes smoked per day. 
Alcohol consumption was assessed as the cumulative number of alcoholic beverages, 
specified in mean grams of alcohol per week.  
Cytomegalovirus (CMV) antibody levels 
Fasted blood samples were taken by venipuncture in ethylenediaminetetraacetic acid 
(EDTA) coated tubes (Vacutainer, BD, Plymouth, UK). Plasma was obtained by 
centrifugation and stored in small aliquots at -80°C until analysis. Evidence of CMV infection 
(serostatus) was determined using a commercially available enzyme-linked immunosorbent 
assay (ELISA) (BioCheck, Inc., CA, USA) according to manufacturer instructions. 
Participants with a borderline seropositive result, classified as a calculated index score >0.85 
and <1.15, were retested. If they remained borderline (N=16), subjects with index scores 
above and below 1.00 were considered positive (CMV+) and negative (CMV-) respectively, 
which is consistent with manufacturer instructions. The sensitivity, specificity, and accuracy 
of the test were reported as 95.0%, 96.7%, and 96.0%, respectively. Because the BioCheck 
assay is not recommended for quantitative determination of antibody levels, CMV-IgG levels 
in CMV+ individuals were again measured by a commercially available ELISA kit (Genesis 
Diagnostics Ltd., Cambridgeshire, UK) according to the manufacturer’s instructions. The 
company-reported within-assay and between assay imprecision was <12%.  
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Inflammation 
Analysis of high sensitivity C-reactive protein (hs-CRP) was performed by 
immunonephelometry using a Behring Nephelometer II (High Sensitivity CRP, Dade 
Behring). The detection limit for hs-CRP was 0.015 mg/L, with intra-assay and inter-assay 
CV% < 10%. All analyses were done at Synlab (Leinfelden, Germany).  
HPA activity 
Salivary cortisol was analyzed using a cortisol luminescence immunoassay 
(sensitivity=.008 µg/dL; intra-CV%≤4.5%; IBL International GmbH, Hamburg, Germany) 
and were performed at the lab of Prof. Kirschbaum, at the Dept. of Biopsychology, TU 
Dresden, Germany. To obtain a cortisol awakening response (CAR) participants were 
instructed to collect saliva immediately upon awakening and 30 minutes after awakening 
(Wüst et al., 2000) using time-labeled saliva collection tubes (polyester salivette, Sarstedt, 
Germany). The participants were provided with a diary to record the exact collection times. 
Further samples were collected at 2 hours post-awakening, at 18:00h, and at 22:00h to 
calculate diurnal cortisol area under the curve (AUC) (Golden et al., 2011). Participants were 
instructed to store the saliva samples in their refrigerator or freezer overnight. On return, all 
samples were immediately frozen at −20 °C until assay (within 8 weeks). 
Statistical analysis 
First, t-tests and χ2 analyses were used to test for differences in covariates of interest 
between CMV+ and CMV– individuals. Binary logistic regression was used to calculate odds 
ratios (OR) and corresponding 95% CIs of CMV infection, adjusting for age and gender. 
CMV-IgG levels (among CMV+ individuals) were log-transformed to approximate a normal 
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distribution. Linear regression analyses were then conducted to test the associations of socio-
demographic and psychological stress measures with CMV-IgG levels. Potential confounders 
(e.g., age, gender, demographics, lifestyle, SES) were entered as covariates. Additional 
adjustments were performed to test cortisol and hs-CRP (log-transformed), as potential 
mediators of the psychological stress-CMV-IgG relationship. The CAR was calculated as the 
difference between the cortisol value at awakening and the value 30 minutes after awakening 
(Kunz-Ebrecht, Kirschbaum, Marmot, et al., 2004). Diurnal cortisol AUC was calculated 
according to the trapezoid rule described elsewhere (Pruessner et al., 2003). Lastly, analyses 
were stratified by education level and job status to test for SES differences in immune 
response to psychological stress. Analyses were carried out with SPSS version 19 (IBM-
SPSS, Chicago, IL, USA).   
Results 
Predictors of CMV infection status 
As shown in Table 3.1, 329 (37%) participants were CMV+. On average, CMV+ 
individuals were older, more likely to be married, and had lower education and job status. 
CMV+ individuals were also more likely to be current smokers, but infection status was 
unrelated to the quantity smoked. These associations remained significant after adjustment for 
age and gender (Table 3.2). Other lifestyle-related factors, such as alcohol intake, BMI, and 
activity levels were not associated with CMV infection status. Measures of psychological 
stress, including anxiety, depression, vital exhaustion, and SF-12 mental health scores were 
also not associated with CMV infection (see Table 3.2).  
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Predictors of CMV-specific IgG antibody levels 
Increased HADS anxiety and depression, vital exhaustion, and lower SF-12 mental 
health scores were all significantly associated with increased CMV-IgG in CMV+ individuals, 
adjusting for age and gender (Table 3.3). After subsequent adjustment for predictors of CMV 
infection status (i.e., marital status, job status, education, smoking), these associations 
remained significant with the exception of depression, which was slightly attenuated (β=.108, 
p=.06) (see Table 3.3). For illustrative purposes, Figure 3.1 presents the average scores for 
each of these psychological parameters by three antibody tertiles (low, middle, and high 
CMV-IgG), showing a near-linear trend for all parameters.  
Notably, none of the factors that predicted serostatus (i.e., education, job status, 
marital status, or smoking) were predictors of CMV-IgG level (Table 3.3). Other lifestyle 
factors (i.e., alcohol intake, BMI, waist-to-hip ratio, and activity level) were likewise not 
significantly associated with CMV-IgG level (all p>.10; analyses not shown).  
Mediation by inflammation and HPA activity 
In light of evidence from in vitro and clinical studies, we aimed to determine if cortisol 
levels and inflammation were 1) associated with CMV reactivation, and 2) might act as 
potential pathways linking stress and CMV reactivation. We found no evidence that cortisol 
levels, either measured as cumulative daily cortisol output (AUC), or CAR, was associated 
with CMV infection or reactivation (all p>.10). Similarly, systemic inflammation, measured 
as serum hs-CRP, was not significantly associated with infection status or CMV-IgG. 
Unsurprising therefore, when HPA parameters and hs-CRP were added to the multivariate 
model, the association between psychological variables and CMV-IgG was unaffected.  
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Exploratory analyses: SES moderates the associations between psychosocial stress and CMV-
IgG level 
Table 3.4 presents analyses of the relationship between psychological predictors 
(anxiety, depression, vital exhaustion, SF-12 mental health) and CMV-IgG stratified by 
education and job status. Linear regressions revealed substantially larger associations among 
those with lower education (apprenticeship or less) or lower job status (no managerial 
responsibility), which only in these groups reached statistical significance (adjustment for age 
and gender). However, formal tests of group x stress interaction did not reach significance (for 
all p>.10).  
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Table 3.1: Participant characteristics. 
 
Overall 
(N=887) 
CMV Status  
 CMV Positive 
N= 329 (37%) 
CMV Negative     
N= 558 (63 %) 
p 
Age (years) 44.7 ± 10.1 46.6 ± 9.8 43.6 ± 10.1 <.001 
Gender (% male) 88 86 89 .240 
Current smoker (% yes) 26 32 23 .003 
Cigarettes/day (in smokers)  13 ± 12 14 ± 11 13 ± 12 .729 
Alcohol consumption (g/day) 19.7 ± 27.9 20.3 ± 26.2 19.3 ± 28.8 .592 
BMI (kg/m2) 24.5 ± 3.5 24.5 ± 3.6 24.6 ± 3.5 .657 
Waist-to-hip ratio 0.92 ± 0.07 0.92 ± 0.07 0.92 ± 0.07 .621 
Activity (kcal/day) 475.4 ± 478.9 467.3 ± 442.1 480.2 ± 499.7 .703 
Married (%) 70 76 66 .003 
Education (%)    .001 
     College/University 15 12 17 -- 
     Vocational training 16 18 15 -- 
     Completed apprenticeship 66 65 67 -- 
     No higher education 3 5 1 -- 
Job status (%) 
   
.009 
     Division/Dept manager 4 4 5 -- 
     Project Leader/process mgr 19 17 20 -- 
     Skilled worker (non-mgr) 71 70 72 -- 
     Semi-skilled worker 6 9 4 -- 
Income (%) 
   
.979 
     > 4000 €/mo 10 9 10 -- 
     2500 - 4000 €/mo 40 41 40 -- 
     1500 - 2500 €/mo 44 44 44 -- 
     < 1500 €/mo 7 6 7 -- 
All are unadjusted comparisons of participant characteristics. A t-test was performed on 
continuous variables and a χ2 for categorical variables. Values are mean ± SD unless otherwise 
stated. 
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Table 3.2: Odds ratios (ORs) for socio-demographic and psychological stress 
factors with CMV infection. 
% CMV+ OR (95% CI)* Ptrend 
Socio-demographic factors  
Education .030 
     College/University 30 1.00 (Reference) 
     Vocational training 41 1.47 (0.87 - 2.49) 
     Completed apprenticeship 38 1.41 (0.92 - 2.15) 
     No higher education 75 5.92 (1.75 - 20.06) 
Job status .030 
     Division/Dept manager 32 1.00 (Reference) 
     Project Leader/process manager 34 1.03 (.477 - 2.23) 
     Skilled worker (non-managerial) 36 1.26 (.616 - 2.58) 
     Semi-skilled worker 60 3.05 (1.18 - 7.85) 
Income .908 
     > 4000 €/mo 36 1.00 (Reference) 
     2500 - 4000 €/mo 38 1.18 (.687 - 2.02) 
     1500 - 2500 €/mo 37 1.22 (.715 - 2.09) 
     < 1500 €/mo 36 1.15 (.517 - 2.55) 
Marital status 
  
.029 
     Single (incl. divorced & widowed) 30 1.00 (Reference) 
     Married 41 1.49 (1.04 - 2.14) 
Smoking .001 
     No 34 1.00 (Reference) 
     Yes 46 1.79 (1.29 - 2.49) 
Psychological stress factors 
 
Depression (HADS) -- 1.05 (.912 - 1.21) .503 
Anxiety (HADS) -- 1.07 (.929 - 1.23) .346 
Mental health score (SF-12) -- .925 (.804 - 1.07) .283 
Vital exhaustion (MQ) -- 1.03 (.893 - 1.19) .688 
Sleep disturbances (Jenkins) -- 1.07 (.927 - 1.23) .356 
Adjusted for age and gender. Psychological stress factors are standardized Z-scores. *95% 
confidence interval. 
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Table 3.3: Standardized regression coefficients for the association of socio-demographic 
and psychological stress factors with CMV-IgG levels within CMV+ individuals 
(n=329). 
 Unadjusted Model 1 Model 2 
Socio-demographic factors 
 
 
 
   
Education 
 
-.047 
 
-.044     -- 
Job status 
 
-.012 
 
-.042     -- 
Income 
 
-.085 
 
-.056     -- 
Marital status (single or married) 
 
-.055 
 
-.012     -- 
Smoking (yes/no) 
 
.104 
 
.102     -- 
Psychological stress factors 
 
 
 
   
Depression (HADS) 
 
.095 
 
.109*  .108† 
Anxiety (HADS) 
 
.137** 
 
.140**  .135* 
Mental health score (SF-12) 
 
-.149** 
 
-.141**  -.137* 
Vital exhaustion (MQ) 
 
.148** 
 
.146**  .142* 
Sleep disturbances (Jenkins) 
 
.145** 
 
.145**  .136* 
Model 1: Adjusted for age and gender; Model 2: Model 1 with additional adjustment for 
education, job status, marital status, and smoking. Significant at *p<.05, **p<.01, †p=.06. 
 
 
 
Table 3.4: Standardized regression coefficients for psychological factors and CMV-IgG 
levels by education level and job status. 
 Low 
Educationa 
(N=220) 
High 
Education 
(N=93) 
Low Job 
Statusb 
(N=246) 
High Job 
Status 
(N=65) 
Depression (HADS) 
 
.144* 
 
-.067  .104  -.022 
Anxiety (HADS) 
 
.113 
 
.111  .135*  .115 
Mental health score (SF-12) 
 
-.176** 
 
-.086  -.141*  -.219 
Vital exhaustion (MQ) 
 
.142* 
 
-.014  .110  .191 
Sleep disturbances (Jenkins) 
 
.181** 
 
.006  .142*  .155 
a Low education is apprenticeship or no completed higher education; high education is 
completed vocational training or university. Missing (n=16). b Low job status is without 
managerial responsibility; high job status is with managerial responsibility. Missing (n=18). 
All analyses were adjusted for age and gender. Significant at *p<.05 & **p<.01.  
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Figure 3.1: Mental health variables by three tertiles of CMV-IgG levels among CMV+  
(n=329). Bars indicate means and standard error of the mean. 
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Discussion 
CMV reactivation has been associated with impaired health and identified as a 
possible causal factor in the age-related decline of immune function. Psychological stress may 
be a determinant of CMV reactivation. The present study revealed consistent associations 
between measures of psychological stress and CMV-IgG in a large occupational sample. 
Higher anxiety, depression, vital exhaustion, and lower subjective mental health were all 
associated with elevated CMV-IgG levels in CMV+ individuals, but these factors were not 
associated with being infected per se. In contrast, lower SES was associated with increased 
odds of infection, but not with CMV-IgG levels. These associations withstood adjustment for 
a range of lifestyle and demographic variables. Overall, then, these findings suggest that 
stress-induced CMV reactivation is a robust phenomenon that can be readily replicated in a 
general population sample, extending what is known for other herpes viruses (e.g., HSV, 
EBV) to a species which has increasingly become a cause of public health concern (Gkrania-
Klotsas et al., 2012; Roberts et al., 2010; Strandberg et al., 2009).  
 As noted by others (e.g., Aiello et al., 2009; Fagundes et al., 2012), most prior studies 
in this area lacked a systematic assessment of well-being and stress (or, at least, did not 
present the data). The current study utilized several validated measures, and the consistency 
across measures is therefore a novel finding in its own right. This consistency contributes to 
the recurrent debate on whether specific psychological factors or a general “negative 
affectivity” factor are better able to account for the health effects of stress (Cohen et al., 1995; 
Joiner et al., 1996; Marsland et al., 2001). While both viewpoints have received ample 
support, the results presented here appear more in line with the latter. It is also conceivable 
that a specific component of the shared variance, other than or in addition to negative affect, is 
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driving the observed associations. For example, there is substantial overlap observed between 
the vital aspects of depressive symptomatology and VE (Vroege et al., 2012) with depression 
reported as responsible for 58% of the variability in VE (Tselebis et al., 2011). Further, this 
hypothesis is consistent with a number of studies linking somatic/vital symptoms (e.g., 
fatigue, bodily signs) rather than cognitive and affective complaints (e.g., low mood, 
worrying) of anxiety and depression with inflammation, poorer health outcomes, and mortality 
(Duivis et al., 2013; Roest et al., 2013).  
The current literature on psychosocial factors and CMV reactivation hinges on the 
assumption that CMV-IgG levels are reflective of viral activity. While this assumption has 
received empirical verification (Besson et al., 2006; Kuo et al., 2008; Van Zanten et al., 1995), 
and is consistent with what has been established for other herpesviridae (e.g., EBV, HSV), 
there are additional factors that may affect virus-specific antibody levels. For example, 
repeated infection with different strains of the same virus (denoted as super-infection) may 
likewise elevate CMV-IgG levels (Novak et al., 2008; Ross et al., 2010). In light of the pattern 
of results, super-infection would seem less likely as an alternative explanation: if elevated 
antibody levels reflected repeated infection, it can logically be expected that at least some of 
the factors that predicted infection (e.g., SES, marital status) would also predict CMV-IgG 
levels. That was not the case here. While it is conceivable that other factors, like genetic 
background, may co-determine antibody levels, and thereby confound the observed 
association, we are not aware of any research identifying such extraneous factors. Hence, 
reactivation is, at present, the most likely explanation for elevated CMV-IgG levels in 
distressed individuals (Glaser & Kiecolt-Glaser, 1994; Kuo et al., 2008). Future longitudinal 
studies linking temporal changes in mood and distress with fluctuation in CMV-IgG may 
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further corroborate this idea (cf. Faulkner & Smith, 2009; Stowe et al., 2007; Strachan et al., 
2011). 
The results showed that the association between CMV-IgG and psychological stress 
was strongest in low-SES individuals (job status, education), and virtually absent in high-SES 
employees. While previous studies have singularly explored a possible stress-CMV or a SES-
CMV association, our investigation is the first to provide preliminary evidence that these 
predictors may interact. This finding adds to a small but growing literature demonstrating that 
SES can moderate the associations between stress and health. For example, in 5-year 
longitudinal study, Carroll et al. (2003) observed that cardiovascular reactivity to acute stress 
was a stronger predictor of blood pressure at follow-up among low-SES subjects than among 
high-SES subjects. Low SES has also been found to predict exaggerated stress reactivity of 
the immune (Brydon et al., 2004) and HPA-system (Gruenewald et al., 2006; Kunz-Ebrecht, 
Kirschbaum, & Steptoe, 2004). The exact mechanism responsible may involve exposure to 
more severe stressors (Grzywacz et al., 2004) or, alternatively, the same stressors having a 
larger impact due to impaired coping resources (Kristenson et al., 2004). The idea of impaired 
coping may translate to the biological level in the form of higher allostatic load (Seeman et al., 
2010), which is consistent with the aberrant acute stress responses observed in low-SES 
individuals (Mcewen & Seeman, 1999). 
The current findings were not consistent with data demonstrating associations between 
lower SES and increased CMV-IgG levels in a nationally representative US sample (Dowd & 
Aiello, 2009). This may be due, in part, to the more restricted SES range of this occupational 
cohort. Specifically, in the cohort analyzed by Dowd and Aiello many had less than high 
school education while in the present study >95% had more than high school education. By 
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including the lowest SES groups, associations with CMV-IgG levels might involve factors 
linked to significant and prolonged deprivation, including distress (cf. Fiscella & Franks, 
1997). 
 Inflammation has been shown to promote CMV reactivation in vitro (O'connor & 
Murphy, 2012) and in experimental animal studies (Cook et al., 2006), but an association was 
not observed in the present study. This finding adds to a body of somewhat confusing 
evidence whereby some studies confirm an association between CMV and inflammation (e.g., 
Aiello et al., 2006; Fagundes et al., 2012; Roberts et al., 2010; Turner et al., 2014), but others 
do not (e.g., Bartlett et al., 2012; Bennett et al., 2012; Schmaltz et al., 2005).  
 Glucocorticoids have likewise been shown to cause CMV reactivation in vitro (Forbes 
et al., 1990; Tanaka, Ogura, Kamiya, Yoshie, et al., 1984). However, we did not observe an in 
vivo association between CMV-IgG and cortisol secretion, measured as the cortisol awaking 
response, diurnal cortisol AUC, or rate of cortisol decline. The lack of an association with 
diurnal HPA activity appears to contrast with the literature on EBV reactivation in vivo 
(Cacioppo et al., 2002; Glaser et al., 1994; Stowe et al., 2000). The reasons for this difference 
remain speculative at this point, but might reflect an intrinsic difference between the two 
viruses, which may explain the weak association between CMV and EBV antibody levels 
observed previously (Fagundes et al., 2012; Ling et al., 2003; Rahman et al., 1989). Also, 
considering the single day “snapshot” assessment of cortisol release in the present study, these 
findings should perhaps be followed up by more long-term assessments – for example via hair 
cortisol levels (cf. Stalder et al., 2013).  
 An important target for further research is also to determine the directionality between 
stress and viral reactivation. Naturalistic studies (e.g., academic stress, space flight) (Glaser et 
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al., 1999; Glaser et al., 1985; Mehta et al., 2000) as well as in vitro studies (Prösch et al., 
2000) provided evidence that stress and stress hormones may drive viral replication. However, 
while less well-explored, there is also data to support a reverse causality, whereby CMV 
reactivation causes psychological changes. This neurological effect may occur due to CMV-
induced inflammatory mediators not measured here (e.g., TNF-α, IL-6, IL-1, IFN-γ) that can 
act directly on the brain (Alcendor et al., 2012). Indirectly, CMV-induced inflammation may 
cause psychological changes by cytokine signaling, via afferent nerve fibers, and participate in 
pathways known to be involved in the development of anxiety, depression, and vital 
exhaustion (Goodkin & Appels, 1997; Raison et al., 2006; Silverman et al., 2007). 
The present sample involved a disproportionate number of males (88%), which limits 
the generalizability of our findings to women. However, exploratory analyses did not provide 
an indication that associations were markedly different in women, and adjusting for gender 
also did not impact the results. Another potential limitation is that the sample was taken from 
a working population, and is subject to the ‘healthy worker’ phenomenon – the sample is 
enriched for those with a higher physical and psychological resilience more likely to stay in 
the work force (Sterling & Weinkam, 1985; Thygesen et al., 2011). Such selection may 
possibly result in an underestimation of the associations between distress and CMV 
reactivation due to a restriction of range (assuming that very high distress scores will be 
relatively absent). Finally, future studies may test if the observed associations would 
generalize to any of the other herpes viruses, such as EBV, HSV or VZV (Glaser & Kiecolt-
Glaser, 2005).  
In conclusion, in one of the largest studies to-date we observed remarkably consistent 
associations between CMV-specific IgG antibody levels, taken to signify viral reactivation, 
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and measures of psychological stress. These associations withstood adjustment for a range of 
confounding variables, including those that were predictive of CMV infection, and tended to 
be stronger in those with lower SES. Inflammation and HPA activity, as measured in the 
present study, did not appear to mediate these associations. Thus, stress-associated CMV 
reactivation seems to be a robust phenomenon that could be readily demonstrated in a healthy 
occupational sample, across a broad age range. 
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CHAPTER 4 : PERSONALITY AND 
CYTOMEGALOVIRUS 
Abstract 
 Personality traits have been shown to predict health and longevity, but the exact 
underlying mechanisms are not clear. The pathway proposed here is that personality traits 
influence rates of infection by altering exposure and/or immune susceptibility to infectious 
agents. The current study used the herpes virus, cytomegalovirus (CMV), as an infection 
model to discern which of these aspects of immunity are impacted by personality traits, and as 
an immune-dominant infection linking personality to health. 
 In a large occupational cohort (N=887, mean age=44, 88% male), questionnaires 
assessed the Big 5 personality traits (extraversion, agreeableness, conscientiousness, 
neuroticism and openness), as well as demographic, socioeconomic (SES), and lifestyle 
factors. Plasma samples were analyzed for both the presence (to indicate infection status) and 
level (as a marker of reactivation) of CMV-specific IgG antibodies (CMV-IgG). Each 
personality trait was entered as an independent variable in logistic and linear regressions 
predicting CMV infection and CMV-IgG, respectively. The influences of the other traits were 
considered by mutually adjusting models for all other traits, and by clustering individuals 
exhibiting the profile known as resilience. 
Every one-point increase in neuroticism was associated with 16% increased odds of 
CMV infection, OR(95% CI)=1.16 (1.05-1.29), p<.01, after adjustment for potential 
confounders and the other Big 5 traits. Linear regressions revealed that increased 
conscientiousness was associated with decreased CMV-IgG levels, β=–.13, p=.05, after the 
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same adjustments. None of the other Big 5 traits, or resilience classification, were associated 
with CMV infection status or CMV-IgG levels in mutually adjusted models. 
This study shows for the first time that personality traits are associated with CMV 
infection and reactivation in a large sample of adults. The personality traits associated with 
CMV infection did not relate to CMV-IgG levels, and vice versa. This finding suggests that 
neuroticism may be related to increased exposure, while conscientiousness may have a 
protective effect on susceptibility to viral reactivation. Thus, this study provides preliminary 
evidence for CMV infection and its reactivation as a link between personality traits, health and 
longevity.  
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Introduction 
There is an extensive literature linking personality with physical health and longevity 
in humans (Chapman et al., 2011; Smith & Mackenzie, 2006; Widiger & Seidlitz, 2002). For 
example, people who are high in some personality traits, such as emotional stability, general 
activity (a facet of extraversion) and conscientiousness, have been shown to live longer than 
those lower in these traits (Chapman, 2013; Chapman et al., 2010; Mroczek et al., 2009; 
Shipley et al., 2007; Terracciano et al., 2008). Similarly, clusters of personality traits have also 
been linked to health; individuals who have high resilience, characterized by low neuroticism 
and high scores on the other Big 5 personality traits (i.e., extraversion, agreeableness, 
conscientiousness and openness to new experiences) (Goldberg, 1990; Mccrae & Costa, 
1987), have been shown to have better subjective health, and reduced disease risk throughout 
the life course (Kinnunen et al., 2012; Tiainen et al., 2013; Wessman et al., 2012). Research is 
now exploring the potential mechanisms through which personality could influence health 
outcomes (reviewed in Smith & Mackenzie, 2006). 
One proposed model is that personality may affect rates of infection, and therefore 
influence health and longevity (Segerstrom, 2000). For this to be a plausible mechanism, 
personality would have to be linked to the risk of infectious exposure (i.e. the likelihood of 
coming into contact with an infectious agent), and/or to the degree of vulnerability to that 
agent (i.e. the likelihood of becoming infected once exposed). There is evidence to support 
both contentions, although they have not yet been explicitly compared in a large sample of 
adults. 
Personality consistently influences the types of behaviors that we engage in, and 
therefore is likely to influence our exposure to infectious diseases. For example, personality 
 56 
 
influences social interaction, sexual behaviors and hand washing practices (Asendorpf & 
Wilpers, 1998; Hoyle et al., 2000), which are all linked to exposure rates for common 
infections (Aiello et al., 2008; Bates et al., 2004; Hawley et al., 2011). Further, a longitudinal 
study demonstrated that those with high neuroticism and low conscientiousness have a greater 
disease burden, as measured by the Charlson Comorbidity Index (CCI) (Sutin et al., 2013). 
The CCI is a weighted sum of 19 clinical conditions found to increase mortality risk, such as 
diabetes, congestive heart failure, and dementia (Charlson et al., 1987). Specifically, increases 
in a sub-trait of neuroticism were associated with a 26% increased risk of developing disease 
and a 36% risk of getting sicker at subsequent follow-ups (Sutin et al., 2013). Similar findings 
with behaviors related to extraversion have been found with parasite load in animal models 
(Koprivnikar et al., 2012).  
As exposure is necessary, but not sufficient for infection to occur, the influence of 
personality on susceptibility to infection may also determine health and longevity. 
Personality-related changes in immune and neuroendocrine systems may increase 
vulnerability to infection in certain individuals (Miller et al., 1999; Sutin et al., 2012). For 
example, high neuroticism, and low extraversion and conscientiousness have been linked to 
markers of immune function, such as reduced vaccination efficacy, stimulated cytokine 
production, and natural killer cell cytotoxicity, as well as increased circulating markers of 
inflammation (reviewed in Cohen et al., 2012). These outcomes may stem from different 
personality types’ propensity to feel and cope in a particular way, which in turn, corresponds 
to physiological responses to environmental stressors (Segerstrom, 2000). Indeed, personality 
traits (e.g., neuroticism) can contribute to a chronic and/or exaggerated activation of the stress 
response (Zobel et al., 2004), ultimately leading to long-term immunosuppression (Glaser & 
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Kiecolt-Glaser, 2005). On the other hand, increased resilience has been associated with 
reduced stress and a favorable profile of stress-related biomarkers (Petros et al., 2013). Taken 
together, personality may influence both exposure to infectious agents as well as the 
susceptibility that allows for infection and subsequent disease progression.  
An elegant in vivo paradigm to study exposure and susceptibility simultaneously is 
measuring the distribution of, and immune responses to, the latent herpes virus, 
cytomegalovirus (CMV). CMV establishes life-long and mostly asymptomatic infection that is 
prevalent in 30%-90% of the population in developed countries. Prevalence increases nearly 
linearly with advancing age (Crough & Khanna, 2009; Staras et al., 2006) and correlates 
negatively with socioeconomic status (SES) (Dowd et al., 2009; Enders et al., 2012; Simanek 
et al., 2009). Temporary weakening of the immune system (e.g., due to psychological stress) 
triggers CMV to reactivate from its dormant state, termed latency, resulting in increased levels 
of CMV-specific IgG antibody (CMV-IgG) (Kuo et al., 2008; Van Zanten et al., 1995). Thus, 
a particularly attractive feature of CMV, as a model of infection, is that higher CMV-IgG 
levels represent a progressive failing of cellular immunity and poorer control over the virus 
(Glaser & Kiecolt-Glaser, 2005). Accordingly, CMV infection reflects a successful 
combination of both exposure and susceptibility, while elevated CMV-IgG antibody levels 
among those infected may specifically reflect impaired immunity and increased susceptibility. 
If a trait is associated with CMV infection and reactivation, then an effect on susceptibility is 
more likely; however, if it is associated with infection only, then exposure is a more plausible 
explanation. Comparing the effects of personality traits on these features of CMV may further 
elucidate their contribution to infectious exposure, susceptibility or both. 
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In recent years it has become evident that CMV infection also has clinical relevance. 
Congenital infection can cause serious neuronal damage to the developing fetus and accounts 
for more cases of birth defects and mental retardation per year than the better-known spina 
bifida, Down syndrome, or fetal alcohol syndrome (Cannon & Davis, 2005; Cheeran et al., 
2009). Although asymptomatic in adults, CMV is also implicated in accelerating the 
biological aging of the immune system (Derhovanessian et al., 2009; Pawelec et al., 2009). In 
immune-compromised individuals (e.g., clinical illness, immunosuppressive therapy), CMV is 
responsible for a plethora of adverse outcomes (Söderberg-Nauclér, 2006; Varani & Landini, 
2011), including increased mortality rates, especially among older adults (Gkrania-Klotsas et 
al., 2012; Pawelec et al., 2012; Simanek et al., 2011; Strandberg et al., 2009). Thus, any 
personality trait-related gradients for CMV infection or reactivation may have wider public 
health implications. 
In a large sample of working-aged individuals, this study examined the relationship of 
the Big 5 personality traits (Goldberg, 1990; Mccrae & Costa, 1987) and a resilience profile 
with CMV infection prevalence (exposure), and with plasma CMV-IgG concentration, which 
reflects impaired control over the virus among those infected (susceptibility). These analyses 
took into account potential confounders of these relationships, including socio-demographic 
(age, gender, marital status, SES) and lifestyle (smoking, alcohol intake, body mass index, 
physical activity) factors known to influence these relationships.  
Materials and Methods  
Participants 
The present study was conducted on a subset of participants from the MIPH Industrial 
Cohort Studies (MICS) (N=887; 88% male; mean age 44; range 19-71) who took part in a 
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voluntary company health check (Li et al., 2013). The majority of subjects worked as non-
managerial skilled workers, had at least completed an apprenticeship, and on average, had a 
BMI near the upper limit of the normal range. Participant characteristics are presented in 
Table 4.1. Participants received a personalized comprehensive health report. All data was 
anonymized before analysis, and this study was approved by the Ethical Committee of the 
Mannheim Medical Faculty, Heidelberg University. All participants signed informed consent. 
Procedures 
Participants arrived in the morning between 06:45h and 08:45h for their health check. 
In a quiet room away from their usual workplace, participants were seated separately to fill 
out questionnaires assessing demographics, medical history, and health behaviors, after a 
fasting blood draw. Anthropometric (e.g., height, weight, waist and hip circumference) and 
blood pressure measurements were carried out by trained study personnel. 
Demographic and lifestyle data 
Demographic data, including age, gender, and marital status, along with SES 
indicators (current job status, education level, or net monthly income in Euros), and lifestyle 
factors (e.g., smoking, alcohol consumption, activity level) were obtained by questionnaires 
used and validated in the MONICA study (Jönsson et al., 1999). Participants were identified 
as current smokers by self report (item: “Do you currently smoke?”). Smoking frequency was 
assessed as the number of cigarettes per day. Alcohol consumption was assessed as the 
cumulative number of alcoholic beverages (specified in equivalent units: e.g., bottle or can of 
beer 0.5 L/unit; red or white wine 0.2 L/unit; liquor 50 mL/glass) taken on average (response 
categories: not at all, 1-3 per month, 1 per week, 2-4 per week, 5-6 per week, 1 per day, 2-3 
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per day, 4-5 per day, 6 or more per day). Answers were converted into total average 
consumption in mean grams/week. Physical activity was derived from the self-reported 
average hours per week spent participating in various activities (e.g., walking, jogging, 
playing tennis). These activity durations were multiplied by their respective caloric 
expenditure, and averaged over seven days to yield a weighted sum of kilocalories per day. 
Big 5 personality traits and the resilience profile 
The personality traits extraversion, agreeableness, conscientiousness, neuroticism, and 
openness to new experiences were assessed with the short version of the Big Five Personality 
Inventory (BFI-10). This questionnaire comprises of 10 statements rated on a 5-point Likert 
scale (1 = “strongly disagree” to 5 = “agree strongly”). Summing the 2 items for each of the 5 
traits results in the possible score range of 2-10, with higher scores indicating greater 
expression of the trait. The BFI-10 was developed simultaneously in several samples in both 
English and German, and compared to the original 44-item instrument (BFI-44) (Goldberg, 
1992) and the NEO Personality Inventory Revised (NEO-PI-R) (Costa & Mccrae, 1992). It 
has been shown to have significant levels of reliability and validity (Rammstedt & John, 
2007). To define the resilience personality profile, we applied Ward’s hierarchical clustering 
procedure (Ward, 1963). This yielded two personality trait clusters that were significantly 
different on each of the Big 5 traits. The cluster that was low in neuroticism and high on all 
other traits were classified as resilient (Kinnunen et al., 2012; Tiainen et al., 2013). 
Cytomegalovirus (CMV) antibody determination 
CMV IgG antibody determination was carried out as described in Chapter 3 above (see 
pg. 38). 
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Statistical analysis 
First, t-tests and χ2 analyses were used to test for differences in Big 5 traits and 
covariates of interest between CMV+ and CMV ̶  groups. Next, binary logistic regressions 
were utilized to calculate odds ratios (OR) and 95% confidence intervals (CI) for CMV 
infection from the Big 5 personality traits, adjusting for potential confounders, such as age, 
gender, marital status, lifestyle factors (smoking, alcohol, physical activity, and body mass 
index), and SES (job status and education), as well as the other Big 5 traits. Then, associations 
between the Big 5 personality traits and CMV-IgG levels among CMV+ individuals were 
assessed by linear regression, adjusting for the abovementioned potential confounders. Lastly, 
associations of the resilience profile (yes/no) with CMV infection and levels of CMV-IgG 
were tested with binary logistic regression and ANCOVA, respectively. Analyses were carried 
out with SPSS version 20 (IBM-SPSS, Chicago, IL, USA).  
Results 
Three hundred and twenty-nine participants (37%) were CMV+. Compared to their 
CMV– counterparts, CMV+ individuals were more likely to be older, married, current 
smokers, and to have lower education and job status (Table 4.1). Other demographic and 
lifestyle factors measured (i.e., gender, alcohol intake, BMI, waist-to-hip ratio, activity level, 
and income) did not differ by CMV status.   
Table 4.2 shows the odds ratios of CMV infection for the Big 5 traits considered 
individually. Every one-point increment in agreeableness and neuroticism increased infection 
odds by 11% and 12%, respectively, after adjustment for age and gender. These associations 
were unaffected by further adjustment for marital status, SES (education and job status), and 
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lifestyle factors (smoking, activity level, alcohol intake, and BMI).  Mutual adjustment for 
other personality traits revealed that neuroticism was significantly associated with a 16% 
increased odds of CMV infection after full adjustment (Model 4). None of the other Big 5 
traits were significant predictors of CMV infection in the mutually adjusted model (all p>.05; 
Table 4.2). 
Among those who were CMV+, none of the individual Big 5 traits were significantly 
associated with plasma CMV-IgG concentration in linear regressions (all p>.05). However, 
when the personality traits were entered together, higher conscientiousness was significantly 
associated with lower CMV-IgG, β=–.13, p=.03, after adjustment for age, gender, marital 
status, and SES (education and job status). This association remained significant after further 
adjustment for lifestyle factors (smoking, activity level, alcohol intake, and BMI), β=–.13, 
p=.05. 
The cluster analysis revealed two personality groups: resilient (n=336) and non-
resilient (n=473) individuals (missing=78). Logistic regressions revealed that being classified 
as resilient was unrelated to CMV infection odds in unadjusted or adjusted models (all p>.05). 
Likewise, CMV-IgG levels among CMV-infected individuals did not differ by resilience 
classification in any model (all p>.10). 
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Table 4.1: Participant characteristics. 
 
Overall 
(N=887) 
CMV Status  
 CMV Positive 
N=329 (37%) 
CMV Negative     
N=558 (63 %) 
p 
Age (years) 44.7 ± 10.1 46.6 ± 9.8 43.6 ± 10.1 <.001 
Gender (% male) 88 86 89 .240 
Current smoker (% yes) 26 32 23 .003 
Cigarettes/day (in smokers)  13 ± 12 14 ± 11 13 ± 12 .729 
Alcohol consumption (g/day) 19.7 ± 27.9 20.3 ± 26.2 19.3 ± 28.8 .592 
Body mass index (kg/m2) 24.5 ± 3.5 24.5 ± 3.6 24.6 ± 3.5 .657 
Waist-to-hip ratio 0.92 ± 0.07 0.92 ± 0.07 0.92 ± 0.07 .621 
Activity (kcal/day) 475.4 ± 478.9 467.3 ± 442.1 480.2 ± 499.7 .703 
Married (%) 70 76 66 .003 
Education (%)    .001 
     College/University 15 12 17 -- 
     Vocational training 16 18 15 -- 
     Completed apprenticeship 66 65 67 -- 
     No higher education 3 5 1 -- 
Job status (%) 
   
.009 
     Division/Dept manager 4 4 5 -- 
     Project Leader/process mgr 19 17 20 -- 
     Skilled worker (non-mgr) 71 70 72 -- 
     Semi-skilled worker 6 9 4 -- 
Income (%) 
   
.979 
     > 4000 €/mo 10 9 10 -- 
     2500 - 4000 €/mo 40 41 40 -- 
     1500 - 2500 €/mo 44 44 44 -- 
     < 1500 €/mo 7 6 7 -- 
All are unadjusted comparisons of participant characteristics. A t-test was performed on 
continuous variables and a χ2 for categorical variables. Values are mean ± SD unless 
otherwise stated. 
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Discussion 
This is the first study to investigate the association between the Big 5 personality traits 
and infection with, and reactivation of (measured as CMV-IgG level), CMV. Agreeableness 
and neuroticism were independently associated with an increased risk of CMV infection; 
however, only neuroticism remained significant when controlling for the other personality 
traits. This association was still significant after controlling for a range of potential 
confounders. However, none of the individual Big 5 personality traits were significantly 
associated with levels of CMV-IgG antibodies among those infected. When all personality 
traits were entered into the analysis together, conscientiousness was inversely associated with 
CMV-IgG levels, and remained significant after full confounder adjustment. These findings 
suggest that neuroticism is associated with increased exposure, while conscientiousness may 
contribute to reduced susceptibility to infection. These associations were not explained by 
socio-demographic or lifestyle factors; however, mutual adjustment for the other Big 5 traits 
influenced the appearance of associations, suggesting that the effects of one trait on immunity 
may be dependent on the configuration of the other traits. 
Table 4.2: CMV infection odds ratios and 95% confidence intervals for the Big 5 personality 
traits. 
Model 1 Model 2 Model 3 Model 4 
Extraversion 1.06 (0.97-1.15) 1.06 (0.97-1.16) 1.06 (0.97-1.16) 1.08 (0.99-1.19) 
Agreeableness 1.11 (1.00-1.24)* 1.12 (1.00-1.24)* 1.12 (1.00-1.25)* 1.12 (1.00-1.25)† 
Conscientiousness 1.02 (0.91-1.14) 1.00 (0.89-1.12) 1.01 (0.90-1.14) 1.00 (0.89-1.14) 
Neuroticism 1.12 (1.02-1.23)* 1.10 (1.00-1.22)* 1.12 (1.02-1.24)* 1.16 (1.05-1.29)** 
Openness 1.08 (0.98-1.19) 1.09 (0.99-1.20) 1.08 (0.98-1.20) 1.08 (0.97-1.19) 
Model 1: adjusted for age and gender.  
Model 2: Model 1 with additional adjustment for marital status, job status, & education. 
Model 3: Model 2 further adjusted for smoking, alcohol intake, BMI and physical activity. Each 
trait was modeled in a separate regression. 
Model 4: Model 3 with additional adjustment for the other Big 5 traits. 
Values are odds ratios (95% confidence intervals). Significant at the *p<.05 level; †p<.06. 
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The current associations of higher neuroticism and conscientiousness with increased 
CMV infection odds and reduced CMV-IgG levels, respectively, draws mixed support from 
another study relating CMV and temperament characteristics. Using Cloninger’s 
Temperament and Character Inventory (TCI), Novotná et al. (2005) found, in a sample of 
N=533 military conscripts, that CMV infection was associated with lower scores for the trait 
novelty-seeking. TCI novelty-seeking is described as a tendency to respond with intense 
excitement to novel stimuli, thereby activating behavior (Wessman et al., 2012). Although the 
Big 5 does not measure novelty seeking, it could be considered the opposite of neuroticism 
which is characterized by anxiety, angry hostility, depression, self-consciousness, and 
vulnerability to stress (Costa & Mccrae, 1992). Thus, the effects with CMV infection and 
higher neuroticism and lower novelty-seeking could be two sides of the same coin. However, 
the above study by Novotná and colleagues also found that novelty-seeking was inversely 
associated with continuous CMV-IgG levels (Novotná et al., 2005), but no relationship was 
found with neuroticism in our study.  
Studies using other infection models (i.e., natural versus experimental exposure) have 
also found associations between neuroticism and infection. An earlier study, by Vickers and 
Hervig (1987) found, in multiple samples  that neuroticism, and the sub-traits anxiety and 
depression, were associated with increased upper respiratory infection (URI) in two large 
groups (N=552 and N=591) of US Navy recruits over up to 53 days of basic training – a 
natural exposure context. Conversely, experimental exposure studies found no such 
associations between neuroticism, measured as negative emotional style or trait negative 
affectivity, and experimental susceptibility to the common cold (Cohen et al., 2012). The 
divergent results among these study designs could possibly provide insight into the 
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interpretation of the current findings. The laboratory exposure and quarantine phase of the 
experimental studies, in effect, removes social and environmental influences that are present 
in a natural context (Segerstrom, 2000). Thus, one could argue that the association with 
neuroticism found here may be attributed to its specific contribution to this exposure variance 
in the natural setting.  
The observed inverse relationship between conscientiousness and CMV-IgG levels in 
the present study adds to a growing literature demonstrating protective effects of this trait on 
mental and physical well-being (Bogg & Roberts, 2013), as well as decreased mortality rates 
(Hagger-Johnson et al., 2012).  It is possible that conscientiousness may exert its protective 
effects on health, in part, through its ability to buffer the effects of stress (Bartley & Roesch, 
2011; Gartland et al., 2012; Murphy et al., 2013), possibly limiting the reactivation of CMV in 
those infected. When drawing from other infection models, the current findings with CMV 
reactivation (as a measure of susceptibility) contrast with one experimental exposure study 
that did not find an association between conscientiousness and cold development after 
experimental exposure (Cohen et al., 1997). However, it is worth mention that this study did 
not adjust for the other Big 5 traits, which may have confounded the association with their 
sickness measure, as has been demonstrated here. Taken together, the association of 
neuroticism with CMV infection and conscientiousness with CMV-IgG levels, but not vice 
versa, suggests that the personality factors related to infection prevalence do not continue to 
relate to control over the virus once infected. However, a combination of both exposure and 
susceptibility factors cannot be definitively ruled out. 
The assumed direction of causation so far has been that personality traits result in 
increased infection odds, rather than infection influencing personality. This is supported by 
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longitudinal data, in which only modest changes in personality have been shown with 
increased disease burden (Sutin et al., 2013). Further, only 2% of the variance in novelty-
seeking was explained by CMV infection in the study by Novotná et al. (2005). However, 
there is some evidence for reverse causation, whereby infectious exposures affect mood and 
behavior, which warrants consideration. For example, animal studies demonstrate that 
microbes in the gastrointestinal tract and viral infection can stimulate the central nervous 
system, modulate the stress response and produce changes in mood, anxiety and depression in 
the host (Ezenwa et al., 2012; Foster & Mcvey Neufeld, 2013; Silverman et al., 2007; 
Silverman et al., 2005). Similar behavioral effects have been documented in humans infected 
with Toxoplasma gondii (Flegr, 2007; Novotná et al., 2005). CMV infection could also lead to 
changes personality traits, via chronic low-grade inflammation and protracted sickness 
behavior (Almanzar et al., 2005; Dantzer et al., 2008; Khan et al., 2002; Maier & Watkins, 
1998; Raison et al., 2006; Trzonkowski et al., 2003). This bi-directional aspect of the host-
microbe relationship would benefit from longitudinal study. One model would be to follow 
CMV-negative transplant patients who are given a CMV+ organ, and track the time-course of 
any subsequent personality changes, compared to patients who received a CMV-compatible 
organ. 
The current study is subject to some minor limitations. There were only two 
personality profiles distinguished by the cluster analyses using the short BFI-10, when at least 
five profiles have been identified in other research (Kinnunen et al., 2012). The current study 
simply classified the second group as ‘non-resilient’, but other profiles may exist within this 
group that differ in health behaviors and stress reactivity, and possibly, in CMV infection 
prevalence and CMV-IgG levels. The variance in this non-resilient group may have 
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contributed to the lack of associations found with resilience. In future studies, the use of a full 
length Big 5 inventory, with a wider range of scores, may allow for the creation of more 
discrete personality profiles to compare. The disproportionate number of males (88%) in the 
current study could have influenced the associations between individual traits, profiles and 
CMV. Documented gender differences exist in both health behaviors and personality profiles 
(Kinnunen et al., 2012; Tiainen et al., 2013) and females were found to have a higher CMV 
prevalence in US representative populations (Bate et al., 2010; Staras et al., 2006). However, 
there were no gender differences in CMV status in the current sample, and gender was 
statistically controlled throughout.  
In conclusion, this study found a robust positive association between neuroticism and 
infection with the immune-dominant CMV and a negative association between 
conscientiousness and CMV-IgG levels among those infected in a large sample. Overall, these 
findings suggest that distinct personality traits are related to CMV exposure compared to that 
of susceptibility. The possibility of a bi-directional relationship between these factors cannot 
be discounted. The current results highlight infection history as a potential pathway between 
personality and health, and warrant further investigations into the mechanisms linking 
personality traits, particularly neuroticism and conscientiousness, and CMV. 
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CHAPTER 5 : ASSOCIATIONS 
BETWEEN PHYSICAL ACTIVITY 
FREQUENCY AND HIGHLY-
DIFFERENTIATED T-CELLS 
Abstract 
 Regular physical activity has been postulated to improve health and longevity, in part, 
via its ability to delay or reverse features of immune aging. A hallmark of immunosenescence 
is the accumulation of highly-differentiated T-cells in peripheral blood, which is partly driven 
by infection with cytomegalovirus (CMV). Preliminary studies have associated increased 
exercise and fitness with reductions in these cells; however, it is unclear whether these 
immune benefits are due to more habitual physical activity participation.  
Participants in a European occupational cohort study, (N=1103, mean age=40, 88% 
male) reported the frequency of mild, moderate, and vigorous leisure-time physical activity, as 
well as socio-demographic, socioeconomic, and lifestyle factors by questionnaire. The 
numbers and proportions of circulating CD8+ effector-memory (EM; CD27–CD45RA–) and 
CD45RA+ effector-memory (EMRA; CD27–CD45RA+) T-cells, systemic inflammation and 
CMV infection status were assessed in whole blood and plasma. 
More frequent mild physical activity was associated with lower numbers and 
proportions of EM and EMRA T-cells. Similarly, increased moderate physical activity 
frequency was inversely associated with EMRA T-cells. These associations remained 
significant after adjustment for a range of potential confounders, but were significantly 
attenuated by additional adjustment for CMV status in CD8+ T-cells. In age-stratified 
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comparisons, increasing physical activity frequency was associated with lower EM and 
EMRA T-cells in those in the upper age tertiles (aged >33 years).  
This study is the first to provide evidence for an inverse relationship between leisure-
time physical activity frequency and the accumulation of differentiated effector T-cells, with 
older individuals demonstrating the greatest benefits. These findings also highlight infection 
with CMV as a moderator of these effects in an intensity- and subset-dependent manner. 
Overall, increased frequency of physical activity may delay features of immunosenescence, 
which may be a mechanism linking physical activity with health and longevity.  
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Introduction 
The health benefits of regular physical exercise are well-established (Autenrieth et al., 
2011; Gillum & Obisesan, 2010; Richard et al., 2014; Woodcock et al., 2011), and are 
especially evident in older adults: compared to their less active or sedentary counterparts, 
older individuals who participate in habitual exercise have lower rates of and better prognosis 
for a range of diseases including cardiovascular disease, cancer and autoimmune diseases 
(Autenrieth et al., 2011; Plasqui, 2008; Soares-Miranda et al., 2014; Sofi et al., 2008; Tardon 
et al., 2005). Physically active individuals also have reduced risk of inflammatory diseases, 
due to the anti-inflammatory effects of exercise (Pedersen, 2009).These age-related causes of 
morbidity and mortality involve common immunological pathways, and it has therefore been 
proposed that exercise benefits health, in part, by enhancing immune function (Bigley et al., 
2013; Romeo et al., 2010). A related, but more specific hypothesis is that exercise enhances 
health by delaying the age-associated decline in immune competence, known as 
immunosenescence (Drela et al., 2004; Kohut & Senchina, 2004; Pascoe et al., 2014; 
Senchina & Kohut, 2007; Simpson et al., 2012; Walsh et al., 2011).  
A hallmark of immunosenescence is the accumulation of highly-differentiated effector 
memory (EM; CD27–CD45RA–) and CD45RA+ effector memory (EMRA; CD27–CD45RA+) 
cytotoxic (CD8+) T-cells in the peripheral blood (Fülöp et al., 2013; Spaulding et al., 1999). 
The latent herpes virus, cytomegalovirus (CMV), is known to potently accelerate the 
accumulation of these T-cells, whereby those infected (CMV+) have on average 3- to 4-fold 
higher circulating numbers than in those uninfected (CMV–) (Chidrawar et al., 2009; 
Derhovanessian et al., 2011; Fülöp et al., 2013; Koch et al., 2007; Kuijpers et al., 2003; 
Pawelec et al., 2006; Pita-Lopez et al., 2009; Turner et al., 2014; Wallace et al., 2011; 
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Wertheimer et al., 2014). These EM and EMRA T-cells are characterized by a diminished 
proliferative capacity, potent pro-inflammatory cytokine production and short telomere 
lengths (Macaulay et al., 2013). Correspondingly, the accumulation of these cells has been 
mechanistically linked to key features of immune aging, such as poorer vaccination efficacy, 
impaired immune responses to previously encountered pathogens, elevated systemic 
inflammation, and decreased average leukocyte telomere length (Effros, 2007; Goronzy & 
Weyand, 2013; Messaoudi et al., 2004). Therefore, factors which combat the accumulation of 
these differentiated T-cells may arguably alleviate the deleterious effects of 
immunosenescence.  
Importantly, studies of aerobic fitness and exercise training have provided preliminary 
evidence that habitual exercise is associated with lower proportions and frequencies of highly-
differentiated T-cells in circulation (Spielmann et al., 2011; Woods et al., 2003). For example, 
Spielmann et al. (2011) found that those in the highest tertile of aerobic fitness, measured as 
maximum oxygen uptake (VO2max), had 37% lower proportions of highly-differentiated CD8+ 
T-cells compared to those in the lowest tertile. On the other hand, there is also evidence that 
the prolonged, exceptionally intense training regimens, as undertaken by elite athletes, may 
instead promote an aged immune profile and increased infection risk (Gleeson & Walsh, 
2012; Moro-Garcia et al., 2014; Prieto-Hinojosa et al., 2014). These findings imply that the 
observed benefits of improved fitness on features of immunosenescence may lie in 
participation in more frequent, but not necessarily more intense physical activity (Simpson & 
Bosch, 2014). However, few studies are available linking habitual physical activity with T-cell 
differentiation. Evidence for such an association can be inferred from studies showing longer 
leukocyte telomere length among those reporting higher levels of leisure-time physical 
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activity, compared to those least active (Cherkas et al., 2008; Ludlow et al., 2008). Thus, 
frequent participation in physical activity may help buffer the effects of age and CMV 
infection on the accumulation of highly-differentiated T-cells, and studies linking these factors 
in larger samples, preferably stratified by intensity, are warranted. 
 To address these issues, the present study utilized a large cohort to examine the 
relationship between the frequency of leisure-time physical activity and the numbers and 
proportions of highly-differentiated T-cell subsets. Analyses were adjusted for CMV infection 
status, and potential confounders and mediators of these relationships were also taken into 
account, such as age, socioeconomic status, lifestyle factors (smoking, alcohol intake, BMI), 
and systemic inflammation (Simanek et al., 2011). Particularly, age has been shown to interact 
with leisure-time physical activity to predict mortality, whereby the greatest reduction in 
mortality risk was observed among physically active individuals aged 60 years and over 
compared to their inactive counterparts (Richard et al., 2014). Thus, further analyses 
examined the impact of physical activity frequency on immunosenescence within age groups. 
It was hypothesized that increased physical activity would be associated with decreased 
numbers and proportions of highly-differentiated CD8+ T cells and it was anticipated that this 
effect would be more pronounced in older individuals. In light of evidence that a specialized 
population of T-cells bearing a non-conventional gamma-delta (γδ) T-cell receptor (γδTCR+ 
T-cells) also expand considerably in a CMV-specific manner (Alejenef et al., 2014; Dechanet 
et al., 1999; Pitard et al., 2008; Vermijlen et al., 2010), the above analyses were repeated for 
this cell subset.  
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Materials and Methods  
Participants 
The present study was conducted among employees (N=1103; 88% male; mean age 40 
± 11; range 18-64) of a large airplane manufacturer in the south of Germany who took part in 
a voluntary health check offered by the company. Participant characteristics are presented in 
Table 5.1. Participants received a personalized comprehensive health report. All data was 
anonymized before analysis, and this study was approved by the ethical committee of the 
Medical Faculty Mannheim, Heidelberg University. All participants signed informed consent. 
Procedures 
Participants arrived at a location away from their usual workplace in the morning 
between 06:45h and 08:45h for their health check. After a fasting venous blood draw and 
medical examinations, participants were seated in a quiet room to fill out questionnaires 
measuring demographic, medical, and health behavior data. Anthropometric (e.g., height, 
weight, waist and hip circumference), as well as blood pressure and resting heart rate 
measurements were carried out by trained study personnel. 
Flow cytometry  
T-cell phenotypes were assessed by flow cytometry. Whole blood samples were 
collected in ethylenediaminetetraacetic acid (EDTA) coated tubes (Sarstedt, Nümbrecht, 
Germany), stored at room temperature, and prepared within 1 hour of collection. Briefly, 30 
μL of whole blood was stained with a combination of the following monoclonal antibodies:  
CD3 APC-Cy7, CD4 PerCP, γδTCR PE, CD8 APC, (BD Biosciences, San José, CA), 
CD45RA FITC, and CD27 PE-Cy7 (BD Pharmingen, San Diego, CA). Following 20 minutes 
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of incubation at room temperature in the dark, 1.5 mL of BD FACS lysing solution was added 
to the mixture, and incubated for another 15 minutes. After a 7-minute centrifugation at 
700xg, the supernatant was removed; the pellet was re-suspended in 250 μL of 2% 
paraformaldehyde solution until analyzed. Data was collected using a FACSCanto II flow 
cytometer (BD Biosciences, San José, CA) and the FACS Diva software (BD Biosciences, 
San José, CA). Spectral overlap was electronically compensated for using single labelled 
antibody tubes. Following acquisition, FCS files were transferred to a third party software 
program (FlowJo v7.6.5, Tree Star, Inc., Ashland, OR) for analysis.  
Cytomegalovirus (CMV) and biochemical analyses 
Plasma from fasted blood samples were obtained and stored in small aliquots at -80C 
until analysis. Evidence of previous CMV infection (serostatus) was determined using a 
commercially available enzyme-linked immunosorbent assay (ELISA) (BioCheck, Inc., CA, 
USA) according to manufacturer instructions. Participants with a borderline seropositive 
result, representing a calculated index score >0.85 and <1.15, were retested (N=9). If they 
remained borderline, only subjects with index scores above 1.00 were considered positive 
(CMV+), per manufacturer instructions. The sensitivity, specificity, and accuracy of the test 
were reported as 95.0, 96.7 and 96.0%, respectively. High-sensitivity C-reactive protein (hs-
CRP) was analyzed by immunonephelometry using a Behring Nephelometer II (High 
Sensitivity CRP, Dade Behring). The detection limit for hs-CRP was 0.015 mg/L, with intra-
assay and inter-assay CV% < 10%. 
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Physical activity frequency 
 Three items, based on the Godin Leisure-Time Physical Activity Questionnaire (Godin 
& Shephard, 1985, 1997), assessed the frequency of mild, moderate, and vigorous physical 
activity. Mild physical activity was defined as engaging activity, such as walking or light 
garden work that minimally accelerated their heartbeat for at least 20 minutes. Moderate 
physical activity (e.g., fast walking, riding a bicycle) accelerated their heartbeat, but didn’t 
make them sweat, whereas vigorous physical activity really got them sweating. Participants 
were asked how often in the past 6 months they engaged in each level of physical activity. 
Response categories were:  (1) hardly ever; (2) one to three times per month; (3) about once a 
week; (4) more than once a week; (5) three times or more often per week.  
Demographic and lifestyle data 
Demographic data, including age, gender, marital status, SES indicators (measured as 
current job status, manual occupation, or shift worker), and lifestyle factors (e.g., smoking, 
alcohol, hours per week in physical activity) were obtained by questionnaires used and 
validated in the MONICA study (Jönsson et al., 1999). Participants were defined as current 
smokers if they answered yes to the question: “Do you currently smoke?” These were treated 
as potential confounding factors, and were controlled in the analyses as described below.  
Statistical Analysis 
To discern differences between CMV+ and CMV– individuals, continuous and 
categorical variables were compared using t-tests and χ2 analyses, respectively. The analyses 
for each of the three intensities of physical activity (mild, moderate, vigorous) were followed 
up by binary logistic regression to calculate odds ratios (OR) and 95% confidence intervals 
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(95% CI) for CMV infection. These analyses were adjusted for potential confounding factors 
that may impact physical activity participation, CMV infection and reactivation, including 
age, gender, marital status, lifestyle (smoking, alcohol, BMI, activity) and SES (job status and 
manual occupation) and systemic inflammation (hs-CRP).  
The association of mild, moderate and vigorous physical activity frequency with the 
numbers and percentages of highly-differentiated CD8+ EM and EMRA T-cells was assessed 
by linear regression. These associations were likewise controlled for the above socio-
demographic, lifestyle, SES factors and hs-CRP. Due to its strong association with the 
accumulation of these cells, a second model was added to the analyses, further adjusting for 
CMV status. These linear regression analyses were repeated using γδTCR+ T-cell subsets as 
dependent variables. 
To examine the impact of age on these relationships, the participants were divided into 
three equal age groups, and the numbers of EM and EMRA CD8+ T-cells were compared by 
analysis of covariance (ANCOVA). Bonferroni-corrected post-hoc comparisons were used to 
examine the effects of the frequency of physical activity (<1x/wk, 1-2x/wk, and >2x/wk) on 
CD8+T-cell subset numbers within each age tertile. Analyses were performed with SPSS 
version 20 (IBM-SPSS, Chicago, IL, USA). 
Results 
Differences between CMV+ and CMV– individuals 
As shown in Table 5.1, 400 (36%) participants were CMV+. On average, CMV+ 
participants tended to be older and married/cohabitating. CMV+ individuals were also more 
likely to be female, current (or former) smokers, to drink alcohol less frequently, and to have 
lower socioeconomic status (low job status and manual occupations, and work in shifts). 
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Among smokers, the amount of cigarettes smoked per day did not differ according to CMV 
status (Table 5.1). Table 5.2 shows the unadjusted participant physical characteristics. CMV+ 
individuals were less likely to engage in mild (p=.020), moderate (p=.041), but not vigorous 
(p=.335) physical activity more than twice per week, compared to their CMV– counterparts. 
However, no other physical characteristics, including BMI, waist-to-hip ratio, self-reported 
hours of activity, and hs-CRP, differed by CMV status in unadjusted analyses (Table 5.2).  
After full adjustment (age, gender, marital status, smoking, alcohol, BMI, job status, 
manual occupation and hs-CRP), binary logistic regressions revealed that, compared to 
inactive individuals, the odds of CMV infection were 54% and 43% lower among those 
participating in mild, OR (95% CI) = .46 (.26 - .82), p=.008, or moderate, OR (95% CI) = .57 
(.35 - .92), p=.021, physical activity three or more times per week, respectively. The 
frequency of vigorous physical activity was not significantly associated with odds of CMV 
infection after full adjustment (p=.49). 
Lower differentiated CD8+ T-cells with increased mild and moderate physical activity 
depends on CMV infection status 
Table 5.3 shows the association between the frequency of physical activity and the 
number and proportion of T-cell subsets in all participants. Increased frequency of mild 
physical activity was associated with decreased numbers and proportions of CD8+ EM and 
EMRA T-cells after adjustment for age, gender, marital status, lifestyle factors (smoking and 
alcohol, BMI), and SES (job status and manual occupation) and hs-CRP. Moderate physical 
activity frequency was also inversely associated with numbers and percentages of CD8+ 
EMRA T-cells. In a second model, additionally adjusting for the effects of CMV status on T-
cell accumulation, the above associations were reduced to non-significance (p<.06) (Table 
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5.3). Due to these attenuations, the possible interaction effect of CMV infection and physical 
activity frequency on CD8+ EM and EMRA T-cell numbers and percentages was tested by 
moderation analyses. However, these analyses did not reveal any evidence for moderation 
(p>.07 for all; data not shown). 
Moderate and vigorous physical activity also showed a significant negative 
relationship with numbers and proportions of total CD8+ T-cells. Only the associations with 
vigorous physical activity remained significant after final adjustment for CMV. Vigorous 
physical activity was not associated with CD8+ EM and EMRA T-cell subsets (Table 5.3). 
Age differences in differentiated CD8+ T-cells 
 Figure 5.1 shows the associations between physical activity frequency and numbers of 
CD8+ EM and EMRA T-cells within each age tertile. First, basic comparisons of T-cell 
numbers between age groups revealed a significant main effect of age for both T-cell subsets 
across all categories (mild, moderate, and vigorous) of physical activity. Specifically, T-cell 
subset numbers in individuals aged 34-45 yrs and 46-64 yrs were, in general, significantly 
higher compared to those 18-33 yrs. There were no differences observed between those 34-45 
yrs and 46-64 yrs (Figure 5.1). Fully adjusted analyses revealed that the main effect of age 
remained significant for EM and EMRA T-cell subsets after controlling for gender, marital 
status, SES (job status and manual occupation), and lifestyle factors (smoking, alcohol, BMI, 
and activity), as well as additional adjustment for CMV status.  
Age-dependent associations between physical activity frequency and the accumulation of 
differentiated CD8+ T-cells 
The possibility of an age-dependent effect of physical activity on T-cell numbers was 
tested by post-hoc comparisons within each age tertile. Physical activity frequency was not 
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associated with CD8+ EM and EMRA numbers in those aged 18-33 yrs. Among individuals 
aged 34-45 yrs, CD8+ EM T-cells were significantly lower in those reporting mild physical 
activity 1-2 times per week, and moderate physical activity more than once per week. Within 
the same age group, CD8+ EMRA were significantly lower in those participating in mild 
physical activity more than twice per week. Among those aged 46-64 yrs, CD8+ EMRA T-
cell numbers were lower in those reporting mild physical activity more than once per week 
(Figure 5.1). With the exception of lower numbers of CD8+ EMRA numbers in those aged 
>33 yrs reporting mild physical activity more than twice per week (both p<.05), the above 
associations did not survive full adjustment. Further adjustment for CMV status attenuated 
these remaining associations. Vigorous physical activity frequency was not associated with 
significantly lower EM or EMRA numbers in any age group. 
Increased mild and moderate physical activity frequency is associated with lower 
differentiated γδTCR+ T-cells 
 The linear regression analyses above were repeated for γδTCR+ T-cell subsets, which 
are also known to expand considerably in response to CMV infection. As shown in Table 5.4, 
more regular mild and moderate physical activity was associated with lower numbers and 
percentages of γδTCR+ EMRA T-cells. Mild physical activity was also negatively associated 
with the numbers of γδTCR+ EM T-cells after full adjustment. In a second model, with 
additional adjustment for CMV status, the relationships between γδTCR+ subsets and 
moderate, but not mild physical activity remained significant (Table 5.4). Moderation analyses 
did not reveal any significant interaction terms between mild and moderate physical activity 
and γδTCR+ T-cell subsets (data not shown). Vigorous physical activity frequency was not 
significantly associated with any of the γδTCR+ T-cell subsets (Table 5.4).  
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Table 5.1: Participant socio-demographic characteristics 
 
CMV Status 
 
Total    
(N=1103) 
Positive 
N=400(36%) 
Negative 
N=703(64%) 
p 
Age 40.1 ± 11.0 41.5 ± 11.1 39.3 ± 10.8 <.001 
Gender (% male) 87.7 84.5 89.5 .019 
Alcohol intake (%) -- -- -- <.001 
  0-2x/month 24.5 30.2 21.3 
 
  1-2x/wk 30.1 32.7 28.6 
 
  3-7x/wk 45.4 37.1 50.1 
 
Smoking (%) -- -- -- .027 
  Never smoker 46.7 41.2 49.8 
 
  Former smoker 24.8 27.0 23.5 
 
  Smoker 28.6 31.8 26.7 
 
Cigarettes per day (in smokers) 14 ± 8 15 ± 7 13 ± 8 .091 
Married/Co-habitating (%) 77.4 81.3 75.2 .028 
Job status (%) -- -- -- <.001 
  Division/dept mgr 3.9 2.1 4.9 
 
  Project leader/process mgr 15.1 13.5 16.0 
 
  Worker (managerial) 6.3 5.5 6.7 
 
  Skilled worker (non-mgr) 65.4 64.6 65.9 
 
  Semi-skilled worker 9.3 14.2 6.4 
 
Shift worker (% yes) 28.1 34.0 24.7 .002 
Manual occupation (% yes)  49.6 55.0 46.5 .008 
All are unadjusted comparisons of participant characteristics. A t-test was performed on 
continuous variables and a χ2 for categorical variables. Values are mean ± SD unless 
otherwise stated. 
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 Table 5.2: Participant physical characteristics. 
  
 CMV Status   
Total 
N=1103 
Positive 
N=400(36%) 
Negative 
N=703(64%) p 
Mild PAa (%) -- -- -- .020 
   <1x/wk 21.2 25.5 18.7 
 
   1-2x/wk 53.5 52.3 54.2 
 
   >2x/wk 25.3 22.1 27.1 
 
Moderate PA (%) -- -- -- .041 
   <1x/wk 28.1 31.4 26.2 
 
   1-2x/wk 50.2 50.6 50.0 
 
   >2x/wk 21.7 17.9 23.8 
 
Vigorous PA (%) -- -- -- .335 
   <1x/wk 31.0 33.2 29.7 
 
   1-2x/wk 52.7 52.2 52.9 
 
   >2x/wk 16.3 14.5 17.3 
 
Body mass index (kg/m2) 24.5 ± 4.0 24.5 ± 4.0 24.5 ± 4.1 .927 
Waist-to-hip ratio 0.90 ± .08 0.90 ± .08 0.90 ± .07 .200 
Activityb (h/wk) 7.0 ± 7.5 7.1 ± 9.4 7.0 ± 6.2 .355 
Resting HRc (bpm) 72 ± 12 72 ± 12 71 ± 12 .080 
Systolic BPd (mmHg) 136 ± 14 135 ± 14 136 ± 13 .280 
Diastolic BP (mmHg) 78 ± 12 78 ± 12 78 ± 12 .665 
hsCRPe  (mg/L) 0.17 ± 0.30 0.16 ± 0.23 0.18 ± 0.33 .517 
 All are unadjusted comparisons of participant characteristics. A t-test was performed on 
continuous variables and a χ2 for categorical variables. aPhysical activity; bleisure-time 
physical activity cheart rate; dblood pressure; ehigh sensitivity c-reactive protein. Values 
are mean ± SD unless otherwise stated. 
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Table 5.3: Standardized regression coefficients for CD8+ T-cell subset numbers and 
percentages and reported frequency of mild, moderate, and vigorous physical activity. 
    Mild Moderate Vigorous 
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 
CD8+ # -.062* -.036 -.072* -.054 -.076* -.069* 
% -.037 -.010 -.076* -.058† -.077* -.070* 
CD8+ EMa # -.083** -.057† -.025 -.007 -.018 -.011 
% -.082** -.057† -.030 -.013 -.013 -.007 
CD8+ EMRAb # -.101*** -.051† -.073* -.039 -.024 -.011 
  % -.093** -.041 -.065* -.030 -.013 .0002 
Model 1: Adjusted for age, gender, marital status, lifestyle factors (smoking, alcohol, 
BMI), and SES (job status, manual occupation), and c-reactive protein (CRP).  
Model 2: Model 1 further adjusted for CMV status.  
Significant at the *p<.05, **p<.01, ***p<.001, and †p<.06 level. aEffector memory; 
bCD45RA+ effector memory. 
 
 
Table 5.4: Standardized regression coefficients for γδTCR+ T-cell subset numbers and 
percentages and reported frequency of mild, moderate, and vigorous physical activity 
    Mild Moderate Vigorous 
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 
γδTCR+ # -.056 -.041 -.050 -.040 -.036 -.032 
% -.031 -.019 -.035 -.027 -.022 -.019 
γδTCR+ EMa # -.065* -.059 -.016 -.011 -.034 -.033 
% -.047 -.049 .009 .007 -.019 -.019 
γδTCR+ EMRAb # -.080* -.043 -.087** -.061* -.038 -.029 
  % -.072* -.032 -.084** -.057* -.018 -.008 
Model 1: Adjusted for age, gender, marital status, lifestyle factors (smoking, alcohol, 
BMI), and SES (job status, manual occupation), and c-reactive protein (CRP). 
Model 2: Model 1 further adjusted for CMV status.  
Significant at the *p<.05 & **p<.01 level. aEffector memory; bCD45RA+ effector 
memory. 
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Figure 5.1: Unadjusted comparisons of numbers of CD27-CD45RA+/- T-cell subsets by age 
and physical activity frequency.   
Significantly different from <1x/wk group at the *p<.05 & **p<.01 level. Significantly 
different from 18-33 yrs group at the 
#
p<.05, 
##
p<.01 & 
###
p<.001 level. Values are Mean ± 
SEM.  
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Discussion 
The present study found that a higher frequency of both mild and moderate physical 
activity was associated with lower EMRA CD8+ and γδTCR+ T-cells, and mild physical 
activity was additionally associated with lower EM CD8+ T-cells. These findings withstood 
adjustment for a wide range of socio-demographic and lifestyle factors, as well as systemic 
inflammation (hs-CRP), indicating that physical activity patterns have a robust impact on the 
accumulation of highly-differentiated T-cells. Overall, these results provide evidence for the 
first time that older individuals participating in increased mild and moderate, but not vigorous 
physical activity, display lower numbers and proportions of highly-differentiated T-cells, 
indicative of a delayed onset of immunosenescence. For the first time, this study examined the 
specialized subset of γδTCR+ T-cells in the context of physical activity frequency and found a 
similar pattern of associations as CD8+ T-cells after full adjustment. 
These findings also highlight infection history as a possible co-determinant of these 
relationships. Adjustment for CMV status influenced the observed relationships in a subset-
dependent manner, whereby CMV attenuated the associations of mild and moderate physical 
activity with CD8+ T-cells, whereas with γδTCR+ T-cells, moderate physical activity 
associations were unaffected. A possible explanation for this pattern may lie in intrinsic 
differences between these two cell types. Although both CD8+ and γδTCR+ T-cells expand 
similarly in response to CMV infection and express a differentiated phenotype (Couzi et al., 
2009; Pitard et al., 2008; Van De Berg et al., 2008), the CMV-specific γδTCR+ T-cell 
population require additional stimulation for activation (Alejenef et al., 2014). Thus, the 
differential attenuation by CMV may reflect distinct effects of a given physical activity 
intensity on the mobilization of CMV-specific CD8+ versus γδTCR+ EM and EMRA T-cells 
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(Simpson, 2011). These γδTCR+ T-cells have a greater exercise intensity-dependent 
mobilization than CD8+ T-cells (Anane et al., 2009), and future studies, stratifying  these  
responses by CMV status, would help confirm or refute this speculation. 
In age-stratified comparisons, increasing physical activity frequency was associated 
with lower EM and EMRA T-cells in the upper two age tertiles (>33 years), but not in the 
lowest tertile (≤33 years). The null findings among the younger individuals may reflect less 
life-long pathogen exposure and a more diverse T-cell pool compared to their older 
counterparts (Le Saux et al., 2012; Palmer, 2013; Pawelec, 2012; Qi et al., 2014). Assuming 
that the effects of physical activity restore balance to dysregulated immune functioning, it 
would not be expected to alter the already competent immune system in these younger 
individuals. The associations in the upper two age tertiles may allude to the benefits of a more 
life-long proclivity to physical activity participation in these older adults. Studies utilizing 
exercise interventions up to 12 months provide little evidence of improvements in T-cell 
immunity, despite marked increases in fitness level. This may suggest that longer periods of 
participation in physical activity are needed to achieve the immune benefits observed in cross-
sectional studies (Simpson et al., 2012). Assuming frequent exercise-related mobilization and 
subsequent deletion of these cells as a mechanism, engaging in habitual physical activity 
throughout the lifespan could culminate in frequent exercise-induced clearance of highly-
differentiated T-cells and/or stimulating preservation of thymic output, possibly via frequent 
cell turnover (Simpson, 2011). Studies aimed at determining a potential optimal range of 
physical activity (in terms of frequency, intensity and volume) needed to positively alter the 
composition of the blood T-cell pool are warranted  (Simpson & Bosch, 2014). 
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The current study has limitations. The cross-sectional study design does not allow for 
causal inferences between physical activity and the accumulation of highly-differentiated T-
cells. The results are presented here in the orientation consistent with previous research 
reporting immune benefits, including longer leukocyte telomere length (Cherkas et al., 2008) 
and lower proportions of so-called senescent T-cells (Spielmann et al., 2011) with increased 
physical activity participation and aerobic fitness. However, progressive T-cell differentiation 
and low-grade inflammation have been suggested to occur simultaneously and reciprocally 
reinforce one another (Macaulay et al., 2013; Moro-Garcia et al., 2013). This pro-
inflammatory state may feed into the so-called sickness behavior and an associated 
withdrawal from physical activity (Maier & Watkins, 1998). The associations found in the 
current study were independent of systemic inflammation, as measured by hs-CRP, suggesting 
other pathways. Another limitation is the lack of an objective fitness measure. However, the 
current study did measure resting heart rate. Resting heart rate is considered a reliable proxy 
of physical fitness, has concurrent validity with self-reported physical activity, and is 
predictive of mortality in epidemiological studies (Batty et al., 2010; Emaus et al., 2010; 
Jensen et al., 2012; Jensen et al., 2013). There were no differences in resting heart rate with 
CMV infection in the current study, and the current associations between physical activity 
frequency and differentiated T-cells was unaffected when resting heart rate was entered into 
an additional model.  
In summary, this is first study to provide evidence for an inverse relationship between 
physical activity frequency and the accumulation highly-differentiated CD8+ and γδTCR+ T-
cells. These findings generalize preliminary findings with exercise and fitness to the wider 
category of physical activity. These relationships were robust to a range of socio-
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demographic, lifestyle, and inflammatory variables previously associated with physical 
activity participation and immunity. Attenuation by CMV status occurred in an intensity- and 
subset-dependent manner, suggesting that infection history may influence the requirements in 
physical activity frequency, intensity and volume necessary for beneficial effects on immune 
composition.  Lower levels of highly-differentiated T-cells observed with more frequent 
physical activity was only apparent among those in the upper two age tertiles (34 years and 
older), which emphasizes that physical activity becomes particularly important as one ages, 
and may suggest that the manifestation of immune enhancements from habitual participation 
becomes apparent later in life. Overall, the current study suggests an alleviating effect of 
physical activity on immunosenescence, which may have considerable implications in the 
wide-spanning benefits on health and mortality.   
 
  
 89 
 
CHAPTER 6 : ELEVATED HBA1C 
LEVELS AND THE ACCUMULATION OF 
DIFFERENTIATED T-CELLS IN CMV+ 
INDIVIDUALS 
Abstract 
Biological aging of the immune system, or immunosenescence, predicts poor health 
and increased mortality. A hallmark of an aging immune system is the accumulation of 
differentiated CD8+ T-cells (CD27–CD45RA+/–; dCTL), which is partially driven by latent 
infection with cytomegalovirus (CMV). Immune impairments reminiscent of 
immunosenescence have also been observed in hyperglycemia, and in vitro studies have 
identified mechanisms by which elevated glucose levels can lead to the accumulation of 
dCTL. The present study explored associations between glucose dysregulation and markers of 
immunosenescence in CMV-positive and -negative individuals.   
Participants in a European occupational cohort study (N=1103, mean age=40, 88% 
male) were assessed for HbA1c and fasting glucose levels, cardiovascular risk factors (e.g., 
lipid profile), numbers of circulating effector-memory (EM; CD27–CD45RA–) and CD45RA+ 
effector-memory (EMRA; CD27–CD45RA+) T-cells, and CMV infection status. Self-report 
and physical examination assessed socio-demographic, health risk (e.g., diabetic status, 
metabolic syndrome components), and lifestyle factors.  
Among CMV+ individuals (n=400), elevated HbA1c was associated with increased 
numbers of EM (B=2.75, p<.01) and EMRA (B=2.90, p<.01) CTL, which was robust to 
adjustment for age, gender, socio-demographic variables, and lifestyle factors. Elevated EM 
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CTL was also positively associated total cholesterol (B=.04, p<.05), applying similar 
adjustments. No associations were observed in CMV– individuals. 
The present study identified consistent associations between unfavorable glucose and 
lipid profiles and accumulation of dCTL in CMV+ individuals. These results provide evidence 
that the impact of metabolic risk factors on immunity and health can be co-determined by 
infectious factors, and provide a novel pathway linking metabolic risk factors with accelerated 
immunological aging.  
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Introduction 
The progressive impairment of immunity with age, known as immunosenescence, is 
thought to underlie increased infection risk and mortality (Effros et al., 2005; Macaulay et al., 
2013; Trzonkowski et al., 2003; Turner et al., 2014) and  may also contribute to several other 
age-associated complications, including low-grade inflammation and increased cardiovascular 
disease (CVD) risk (Franceschi, Bonafè, et al., 2000; Freitas et al., 2012; High et al., 2005; 
Lindstrom & Robinson, 2010; Luz Correa et al., 2014; Montoya-Ortiz, 2013; Prelog, 2006; 
Salpea & Humphries, 2010; Sansoni et al., 2008). Infection with cytomegalovirus (CMV) has 
been shown to accelerate features of immunosenescence (Chidrawar et al., 2009; Dowd et al., 
2013; Qiu et al., 2008; Turner et al., 2014; Van De Berg et al., 2010). This herpes virus 
establishes a life-long infection during which the virus remains latent, interrupted with periods 
of non-clinical reactivation. The resultant activation of CMV-specific T-cells leads to a 
marked accumulation of differentiated memory cytotoxic T-cells (dCTL; CD27–CD45RA+/–), 
which can be subdivided into effector memory (EM; CD27–CD45RA–) and CD45RA+ 
effector memory (EMRA; CD27–CD45RA+) (Chidrawar et al., 2009; Van De Berg et al., 
2008; Wallace et al., 2011). Indeed, infected (CMV+) individuals have on average 3- to 4-fold 
higher dCTL numbers compared to those uninfected (CMV–), although large individual 
differences exist (Derhovanessian et al., 2011; Koch et al., 2007; Kuijpers et al., 2003; 
Pawelec et al., 2006; Pita-Lopez et al., 2009; Wertheimer et al., 2014).  
The accumulation of dCTLs may make a material contribution to the acceleration of 
immunosenescence (Messaoudi et al., 2004) and is thought to provide a mechanism through 
which immunosenescence may be associated with health outcomes, such as CVD (Macaulay 
et al., 2013).  For example, these T-cells show a high production of pro-inflammatory 
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cytokines, have short telomeres, and have an aberrant proliferative capacity (Akbar & Henson, 
2011; Almanzar et al., 2005; Hamann et al., 1997; Moro-Garcia et al., 2012; Wallace et al., 
2011). It is through the accumulation of dCTL that CMV may be associated with hallmarks of 
an aged immune system.  
Significantly, many of the immune system impairments that have been associated with 
aging resemble those of chronic hyperglycemia. For example, impaired glucose tolerance and 
diabetes are associated with poor control of infection (Allard et al., 2010; Joshi et al., 1999; 
Shah & Hux, 2003), impaired vaccination responses (Egawa et al., 2014), elevated 
inflammatory activity (Esposito et al., 2002; Marfella et al., 2003), and shorter leukocyte 
telomere length (Adaikalakoteswari et al., 2007; Salpea & Humphries, 2010). These 
observations raise the question if the immune effects may, at least in part, involve the 
accumulation of dCTL (Maciver et al., 2008).  For example, studies in vitro show that strong 
T-cell stimulation – similar to that which might be elicited by CMV reactivation – enhances 
cellular glucose uptake, which can lead to the accumulation of readily activated memory T-
cells that acquire resistance to cell death (Jacobs et al., 2008; Zhao et al., 2007). This presents 
a potential mechanism whereby hyperglycemia may amplify the CMV-induced accumulation 
of dCTL.   
Therefore, the aim of the current study was to examine the relationship between 
glucose metabolism (i.e., HbA1c, fasting glucose, and diabetic status) and EM and EMRA T-
cell numbers in a large sample of CMV+ and CMV– individuals. It was hypothesized that the 
effects of CMV infection on dCTL numbers would be enhanced in CMV+ individuals that 
show evidence of elevated glucose. Additionally, other factors associated with hyperglycemia, 
including markers of dyslipidemia (i.e., elevated circulating triglycerides and LDL 
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cholesterol, and lower HDL cholesterol) and elements of the metabolic syndrome (Ahmad 
Khan, 2007; Vinodmahato et al., 2011), may also contribute to increased dCTL accumulation, 
and were determined as well. 
Materials and Methods  
Participants 
The present study was conducted among employees (N=1103; 88% male; mean age 
40; range 18-64) of a large European airplane manufacturer in the south of Germany who took 
part in a voluntary company health check in 2011. Participant characteristics are presented in 
Table 6.1. Participants received a personalized comprehensive health report. All data was 
anonymized before analyses, and this study was approved by the ethical committee of the 
Medical Faculty Mannheim, Heidelberg University. All participants signed informed consent. 
Procedures 
Participants arrived at a location away from their usual workplace in the morning 
between 06:45h and 08:45h for their health check. After a fasting venous blood draw and 
medical examinations, participants were seated in a quiet room to fill out questionnaires 
measuring demographic, medical, and health behavior data. Anthropometric (e.g., height, 
weight, waist and hip circumference) and blood pressure measurements were carried out by 
trained study personnel. Demographic data, including age, gender, and marital status, along 
with SES indicators (measured as hierarchical job position, manual occupation, and shift 
work), self- and doctor-diagnosed medical conditions, and lifestyle factors (e.g., smoking, 
alcohol intake, exercise) were obtained by questionnaires used and validated in the MONICA 
study (Jönsson et al., 1999).  
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Flow cytometry  
Flow cytometry was carried out as described in Chapter 5 (see pg. 74-75). 
Cytomegalovirus (CMV) status determination 
Fasting plasma samples were stored in small aliquots at -80°C until analysis. Evidence 
of previous CMV infection (serostatus) was determined using a commercially available 
enzyme-linked immunosorbent assay (ELISA) (BioCheck, Inc., CA, USA) according to 
manufacturer instructions. Optical density values obtained from participant samples were 
fitted to a standard curve. These concentrations were then compared to a cut-off value to 
compute CMV index scores. Participants with a borderline seropositive result, representing a 
calculated index score >0.85 and <1.15, were retested (N=9). If they remained borderline, 
subjects with index scores above and below 1.00 were considered positive (CMV+) and 
negative (CMV–) respectively, as per manufacturer instructions. The sensitivity, specificity, 
and accuracy of the test are reported as 95.0, 96.7 and 96.0%, respectively.  
Biochemical analyses 
HbA1c, fasting glucose, triglycerides, low-density lipoprotein-cholesterol (LDL-C) 
and high-density lipoprotein cholesterol (HDL-C) and high-sensitivity C-reactive protein (hs-
CRP) were measured by an accredited clinical laboratory (Synlab Laboratories, Augsburg, 
Germany; http://augsburg.synlab.de) according to standard laboratory procedures complying 
with International Organization for Standardization norms (DIN EN ISO 15189). HbA1c was 
measured by a second-generation hemoglobin A1c immunoassay (Roche Diagnostics, 
Mannheim, Germany) and fasting glucose was measured by the glucose hexokinase enzymatic 
assay (Olympus Glucose OSR6121), in accordance with the latest standardized guidelines and 
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recommendations for laboratory analysis in the diagnosis of diabetes (Sacks et al., 2002). 
Cholesterol and triglycerides were automatically measured enzymatically (Cobas 8000 
analyzer, Roche Diagnostics, Mannheim, Germany). HDL-C was measured using a 
competitive homogeneous assay (Roche Diagnostics, Mannheim, Germany), and LDL-C was 
calculated using the Friedewald equation (Friedewald et al., 1972). These values were also 
used to calculate the ratio of LDL-C to HDL-C. 
Diabetes & metabolic syndrome classification 
Diabetes was classified in accordance with to the American Diabetes Association 
guidelines as individuals with fasting glucose ≥126 mg/dL and/or HbA1c ≥6.5% in the 
absence of known diabetes. Those with self-reported doctor-diagnosed diabetes were also 
classified as diabetic. Pre-diabetes was classified as fasting glucose between 100 and 125 
mg/dL and/or HbA1c between 5.7% and 6.4% (American Diabetes Association [ADA] 2013). 
The remaining normal-glycemic individuals, therefore, had fasting glucose and HbA1c levels 
<100 mg/dL and <5.7%, respectively. The metabolic syndrome components were assessed as 
the following: (1) waist circumference >102 cm (men) >88 (women); (2) plasma triglycerides 
>150 mg/dL; (3) plasma HDL-C <40 mg/dL (men) <50 (women); (4) blood pressure ≥130 
(systolic) and/or ≥85 (diastolic) mmHg; (5) plasma fasted glucose ≥100 mg/dL. Each of these 
components were dichotomized (yes or no), and were added together to create a metabolic 
syndrome component score (range = 0-5). Those with a score ≥3 were classified as having 
metabolic syndrome (Grundy et al., 2005). 
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Statistical Analysis 
To approximate a normal distribution of the variables used in the current analyses, we 
applied transformations based on information criteria obtained from the Ladder-of-Powers in 
STATA version 12 (StataCorp LP, College Station, TX). The transformation with the least 
statistical deviation from a normal distribution, indicated by the smallest χ2 (or the most non-
significant p-value) was used, as recommended (Gould & Hilbe, 1991). Missing data (<7% for 
all variables) was handled by multiple imputation in SPSS version 20 (IBM-SPSS, Chicago, 
IL, USA). Briefly, a fully conditional specification method was automatically chosen to 
replacing missing data. In this method, each variable was fit in a univariate (single dependent 
variable) model using all other available variables in the model as predictors, and missing 
values were imputed for each variable being fit. Linear and logistic regressions were used for 
continuous and categorical variables, respectively. Relevant variables with already complete 
data were entered only as predictors to improve estimates. After 10 iterations for each of 5 
imputation datasets, the pooled estimates were used for all subsequent analyses below.  
Firstly, participant characteristics, in terms of demographics and lifestyle behaviors, 
were compared between CMV+ and CMV ̶  individuals. T-tests and χ2 analyses were used for 
continuous and categorical variables respectively.  
Secondly, differences in CMV status with HbA1c, fasting glucose and diabetic status 
were explored using binary logistic regressions. CMV status was entered as the dependent 
variable, and each of the above factors were entered, in turn, as an independent variable. 
Potential confounders known to impact CMV infection and reactivation were statistically 
controlled, including age, gender, marital status, socioeconomic status (job status, manual 
occupation)  (Savva et al., 2013; Simanek et al., 2011), and lifestyle factors (smoking, alcohol 
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intake, BMI, and physical activity) (Hausenloy & Yellon, 2008) in stepwise models. Model 1 
was adjusted for age and gender. Model 2 was additionally adjusted for marital status and SES 
(job status and manual occupation). Model 3 was further adjusted for smoking, alcohol, BMI 
and physical activity. These models were used throughout the remaining analyses. 
Thirdly, numbers of CD8+ EM and EMRA T-cells were compared between levels of 
glycemic control, indicated by diabetic classification, using analysis of (co)variance 
(AN(C)OVA). These analyses were stratified by CMV status and the abovementioned 
potential confounders were entered as covariates (Models 1-3). 
Finally, linear regressions were used to explore the associations between HbA1c, 
fasting glucose, and EM and EMRA T-cell subset numbers; potential confounders were 
entered as covariates using the same models as above.  
The above analyses were repeated with each of the dyslipidemia and CVD risk factors 
(i.e., total cholesterol, LDL-C, HDL-C, the ratio of LDL-C to HDL-C and triglycerides) 
entered separately as independent variables. HbA1c was added as an additional adjustment to 
significant associations to clarify the impact of glucose levels on lipid metabolism. All 
analyses were performed with SPSS version 20 (IBM-SPSS, Chicago, IL, USA).  
Results 
Participant characteristics 
As shown in Table 6.1, 400 (36%) of the participants were CMV+. On average, 
CMV+ participants tended to be older and female. They were also more likely to be current or 
former smokers, to drink less frequently, to have lower socioeconomic status (low job status 
and more manual occupations and shift work). There was no difference in the amount of 
cigarettes smoked (among smokers), BMI, waist-to-hip ratio, or physical activity (all p’s >.10; 
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Table 6.1). Tabulation of metabolic risk factors revealed that N=290 (26.3%) individuals met 
the criteria for metabolic syndrome classification. Diabetes classification resulted in three 
groups: 663 normal, 404 pre-diabetic, and 36 diabetic individuals. Because of the small 
number of diabetic individuals these were merged with the pre-diabetic group, and labeled 
“hyperglycemic”. 
Glycemic control, CMV infection and dCTL numbers 
Unadjusted analyses showed that CMV+ individuals were more likely to have higher 
levels of HbA1c and to be classified as hyperglycemic (i.e., pre-diabetic or diabetic) (Table 
6.2). In binary logistic regressions, these associations of HbA1c and hyperglycemic status 
with CMV infection status were reduced to non-significance after adjustment for age and 
gender (Model 1) and socio-demographic factors (Model 2), respectively. Figure 6.1 shows 
the unadjusted comparisons of EM and EMRA T-cell numbers stratified by glycemic status 
and CMV infection. In all subjects, individuals classified as hyperglycemic had 26.6% higher 
numbers of EM (110.2 versus 87.0 cells/µL) and 41.2% (218.1 versus 154.5 cells/µL) higher 
EMRA T-cells (both p<.001), than normoglycemic participants. 
When further stratified by CMV status, the results showed that EMRA T-cells were 
significantly higher in hyperglycemic versus normoglycemic CMV+ individuals (p<.001), 
while no such difference was observed in the CMV ̶  group (Figure 6.1). This effect survived 
full adjustment, and was accompanied by a significant CMV status by glycemic status 
interaction for EMRA levels (F(1,982)=4.65, p=.031). These effects also did not appear driven 
by the small group of diabetic individuals, as identical results were found when diabetics were 
excluded from analyses (data not shown). Analyses adjusted for age and gender showed that 
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EM T-cells were not significantly higher in hyperglycemic individuals, compared to the 
normoglycemic group. 
Linear associations with dCTL numbers 
Table 6.3 shows the linear associations of metabolic factors with dCTL numbers. 
Overall, higher levels of continuous HbA1c were associated with increased numbers of dCTL 
after adjustment for age, gender, marital status, and SES (job status and manual occupation) 
(Model 2). These associations also remained significant after additional adjustment for 
lifestyle factors (Model 3). Fasting glucose was not significantly associated with dCTL 
numbers in all subjects (Table 6.3). When analyses were stratified by CMV status, the 
relationship between HbA1c and increased dCTL numbers remained in CMV+, but not 
CMV– individuals.  
Dyslipidemia factors 
Unadjusted comparisons of dislipidemia factors between CMV+ and CMV ̶   
individuals revealed that CMV+ individuals also had a higher likelihood to have HDL-C 
levels that fell within the metabolic syndrome classification range (men: <40 mg/dL; women: 
<50). However, none of the other metabolic characteristics, including metabolic syndrome 
classification, differed by CMV status in unadjusted analyses (Table 6.2). After progressive 
adjustment for possible confounders (Models 1-3), the above association with the metabolic 
syndrome HDL-C category was no longer significant, but increased levels of continuous 
HDL-C became significantly associated with CMV infection (OR (95% CI)=0.55 (.319-.960), 
p=.035); that is, higher HDL-C (natural log) predicted a lower risk of CMV infection. 
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In all subjects, linear regressions showed that higher levels of triglycerides were 
associated with increased numbers of dCTL, after adjustment for possible confounders 
(Models 1-3) (Table 6.3). Lower HDL-C and a higher LDL-C/HDL-C ratio were also 
significantly associated with increased EM and EMRA numbers after adjustment for socio-
demographic factors (Model 2). Except for the LDL-C/HDL-C association with EM T-cells, 
these relationships were attenuated by additional adjustment for lifestyle factors (Model 3). 
Total cholesterol and LDL-C were not significantly associated with dCTL numbers in all 
subjects (Table 6.3).  
When analyses were stratified by CMV status, the relationship between triglycerides 
and increased dCTL numbers was found only among CMV+ individuals. Additionally, in the 
CMV+ group, total cholesterol and LDL-C/HDL-C ratio were positively associated EM T-cell 
numbers after adjustment for socio-demographic factors (Model 2) (both p<.05), although 
only cholesterol remained significant after full adjustment (Model 3) (Table 6.3).  
 To test the influence of glucose metabolism on the significant lipid profile 
associations in CMV+ individuals (i.e., triglyceride and cholesterol), HbA1c was additionally 
entered into each of these fully adjusted models. After the addition of HbA1c to the model, the 
above associations between triglycerides and dCTL were attenuated, while the relationship 
between cholesterol and EM T-cells remained significant (data not shown). Among CMV– 
individuals, no significant associations were observed between any metabolic factors and 
dCTL numbers (Table 6.3). 
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Table 6.1: Participant socio-demographic and lifestyle characteristics. 
 
CMV Status 
 
Total 
N=1103 
Positive 
N=400(36%) 
Negative 
N=703(64%) 
p 
Age 40.1 ± 11.0 41.5 ± 11.1 39.3 ± 10.8 <.001 
Gender (% male) 87.7 84.5 89.5 .020 
Married/Co-habitating (%) 77.0 80.4 75.0 .065 
Job status (%) -- -- -- .007 
  Division/dept mgr 4.8 3.5 5.6 -- 
  Project leader/process mgr 15.3 13.9 16.2 -- 
  Worker (managerial) 6.7 6.0 7.1 -- 
  Skilled worker (non-mgr) 63.8 62.6 64.4 -- 
  Semi-skilled worker 9.4 14.1 6.7 -- 
Shift worker (% yes) 28.1 33.8 24.9 .003 
Manual occupation (% yes)  49.6 55.0 46.5 .008 
Smoking (%) -- -- -- .050 
  Never smoker 46.1 41.1 48.9 -- 
  Former smoker 24.9 27.0 23.8 -- 
  Smoker 29.0 31.9 27.3 -- 
Cigarettes per day (in smokers) 14 ± 8 15 ± 7 13 ± 8 .090 
Alcohol (%) -- -- -- <.001 
  0-2x/month 24.9 30.4 21.7 -- 
  1-2x/wk 29.9 32.5 28.5 -- 
  3-7x/wk 45.2 37.2 49.8 -- 
Body mass index (kg/m2) 24.5 ± 4.0 24.5 ± 4.0 24.5 ± 4.1 .929 
Waist-to-hip ratio 0.90 ± .08 0.90 ± .08 0.90 ± .07 .190 
Leisure physical activity (h/wk) 7.0 ± 7.5 7.1 ± 9.4 7.0 ± 6.2 .307 
All are unadjusted comparisons of participant characteristics. A t-test was performed 
on continuous variables and a χ2 for categorical variables. Values are mean ± SD 
unless otherwise stated. 
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Table 6.2: Participant metabolic characteristics. 
 
CMV Status 
 
Total 
N=1103 
Positive 
N=400(36%) 
Negative 
N=703(64%) 
p 
HbA1c (%) 5.61 ± .01 5.64 ± .02 5.60 ± .01 .047 
HbA1c (mmol/mol) 37.84 ± .11 38.13 ± .18 37.67 ± .13 .060 
Fasting glucose (mg/dL) 86.75 ± .29 87.28 ± .50 86.45 ± .36 .168 
Total cholesterol (mg/dL) 202.80 ± 1.20 203.73 ± 2.00 202.27 ± 1.50 .591 
LDL cholesterol (mg/dL) 123.58 ± 1.05 124.47 ± 1.76 123.08 ± 1.30 .580 
HDL cholesterol (mg/dL) 54.06 ± .45 53.23 ± .78 54.53 ± .55 .068 
LDL-C/HDL-C ratio 2.47 ± .03 2.54 ± .05 2.42 ± .04 .140 
Triglycerides (mg/dL) 125.70 ± 2.41 130.13 ± 4.07 123.19 ± 2.98 .145 
Diabetes classification (%) -- -- -- .005 
  Normal 60.1 53.9 63.6 -- 
  Pre-diabetes 36.6 41.9 33.7 -- 
  Diabetes 3.3 4.3 2.7 -- 
Metabolic syndrome (% yes) 26.3 28.0 25.3 .368 
  Waist circumference (% yes) 52.1 54.0 51.0 .387 
  Triglycerides (% yes) 31.8 35.0 30.0 .101 
  HDL-C (% yes) 17.7 21.0 15.8 .036 
  Blood pressure (% yes) 52.5 49.5 54.2 .150 
  Fasting glucose (% yes) 10.0 11.0 9.4 .442 
 All are unadjusted comparisons of participant metabolic characteristics. A t-test was 
performed on continuous variables and a χ2 for categorical variables. Values are mean ± 
SD unless otherwise stated. 
 
 
 
 
  
Figure 6.1: Unadjusted comparison of EM and EMRA T
Significantly different from normoglycemic at the *p<.05 & ***p<.001 level. Significantly 
different from CMV– at the 
 
 
 
 
 
 
 
 
 
 
 
 
-cell subset numbers by glycemic 
status and CMV infection. 
###p<.001 level. Values are mean ± SEM.  
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Table 6.3: Unstandardized coefficients from linear regressions of metabolic factors and EM and 
EMRA T-cell numbers. 
All Subjects (N=1103 ) 
EM (CD27-CD45RA-) EMRA (CD27-CD45RA+) 
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
HbA1c  2.03(.58)*** 1.87(.59)*** 1.54(.59)* 2.20(.77)** 2.05(.77)** 1.68(.78)* 
Fasting glucose 2.15(2.06) 2.31(2.06) 3.23(2.07) -2.92(2.69) -2.74(2.70) -1.72(2.73) 
Cholesterol .011(.01) .013(.01) .014(.01) .012(.01) .014(.01) .015(.01) 
LDL-C .011(.01) .013(.01) .012(.01) .011(.01) .013(.01) .010(.01) 
HDL-C -.134(.05)** -.125(.05)** -.062(.05) -.155(.06)** -.146(.06)* -.076(.06) 
LDL-C/HDL-C .198(.07)** .200(.07)** .140(.07)* .206(.09)* .209(.09)* .131(.10) 
Triglycerides .143(.05)** .134(.05)** .111(.05)* .210(.07)** .203(.07)** .177(.07)* 
CMV Negative (N=703) 
EM (CD27-CD45RA-) EMRA (CD27-CD45RA+) 
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
HbA1c .974(.65) .860(.65) .458(.66) .869(.23) .939(.82) .480(.84) 
Fasting glucose 2.34(2.18) 2.40(2.18) 3.75(2.23) -1.25(2.77) -1.29(2.77) .359(2.84) 
Cholesterol .001(.01) .002(.01) .001(.01) .012(.01) .011(.01) .007(.01) 
LDL-C .004(.01) .005(.01) .003(.01) .010(.01) .009(.01) .005(.01) 
HDL-C -.086(.05) -.084(.05) -.030(.05) -.022(.06) -.030(.06) .024(.07) 
LDL-C/HDL-C .112(.07) .117(.07) .055(.08) .083(.09) .085(.09) .012(.10) 
Triglycerides .066(.06) .059(.06) .028(.06) .120(.07) .129(.07) .085(.07) 
CMV Positive (N=400) 
EM (CD27-CD45RA-) EMRA (CD27-CD45RA+) 
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
HbA1c  3.11(1.03)** 3.02(1.03)** 2.75(1.03)** 3.02(1.00)** 2.92(1.01)** 2.90(1.02)** 
Fasting glucose 2.41(3.82) 2.19(3.83) 2.36(3.83) -3.86(3.72) -3.78(3.74) -3.40(3.77) 
Cholesterol .035(.02)* .036(.02)* .038(.02)* .027(.02) .029(.02) .028(.02) 
LDL-C .026(.01) .027(.01) .027(.01)* .018(.01) .020(.01) .019(.01) 
HDL-C -.112(.08) -.103(.08) -.044(.09) -.109(.08) -.102(.08) -.064(.09) 
LDL-C/HDL-C .265(.12)* .256(.12)* .219(.13) .211(.12) .215(.12) .175(.13) 
Triglycerides .224(.09)* .218(.09)* .201(.10)* .228(.09)* .222(.09)* .206(.10)* 
Model 1: Adjusted for age and gender 
Model 2: Model 1 with additional adjustment for marital status and SES (job status and manual 
occupation) 
Model 3: Model 2 further adjusted for smoking, alcohol, BMI and physical activity.  
Values are beta (standard error). Significant at *p<.05, **p<.01, & ***p=.001. 
 
Discussion 
A hallmark of an aging immune system is the accumulation of differentiated CD8+ T-
cells, which is strongly enhanced in CMV-infected individuals. The present study 
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demonstrated that impaired glycemic control, measured as HbA1c levels, is associated with 
elevated numbers of dCTL in CMV+ individuals, but not in those who are CMV–. This 
association was robust to adjustment for demographics, SES, and lifestyle factors. Thus, the 
present findings are the first to provide evidence that glycemic control may contribute to 
immunosenescence by amplifying the effects of CMV on T-cell differentiation. This 
mechanism may contribute to the impaired immunity seen in hyperglycemia and diabetic 
patients, and may possibly be a pathway linking CMV to increased CVD risk. 
HbA1c may be positively associated with dCTL in CMV+ individuals due to a 
synergistic impact on both the extent of the CMV replication and the T-cell response to CMV 
activity. Elevated glucose levels may (1) directly and indirectly increase the efficacy and 
frequency of CMV replication and (2) allow for enhanced T-cell responses to CMV. Firstly, 
CMV-induced upregulation of the glucose transporter, GLUT4, enhances glucose uptake 
(Landini, 1984; Mcardle et al., 2012; Yu, Maguire, et al., 2011). This excess glucose influx is 
diverted towards the biosynthesis of fatty acids, which are used to directly increase viral 
production and enhance infectivity (Chambers et al., 2010; Munger et al., 2008; Seo & 
Cresswell, 2013; Spencer et al., 2011; Yu, Clippinger, et al., 2011). Indirectly, elevated 
glucose promotes the production of reactive oxygen species (ROS), which is known to 
facilitate the reactivation of CMV by stimulating the CMV promoter region (a required first 
step for CMV reactivation) (Cohen et al., 2011; Demissie et al., 2006; Jaganjac et al., 2010; 
Jain, 1989; Muriach et al., 2008; Self-Medlin et al., 2009). Secondly, evidence from in vitro 
studies demonstrate that strong, repeated antigen receptor stimulation (e.g., by CMV) can lead 
to the upregulation of GLUT1, and enhanced glucose uptake by T-cells. Excess glucose 
uptake was shown to parallel increased T-cell activation, pro-inflammatory cytokine 
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production, as well as an elevated threshold for cell death (Jacobs et al., 2008; Maciver et al., 
2008; Ramakrishnan et al., 2010; Zhao et al., 2007). Although not directly investigated in the 
present study, these represent biologically plausible mechanisms through which elevated 
glucose could augment dCTL numbers via CMV activity. 
The attenuation of the relationship between hyperglycemia and CMV infection by 
socio-demographic factors is in line with other studies finding null associations after similar 
adjustments (Haeseker et al., 2013; Hausenloy & Yellon, 2008; Lutsey et al., 2009), but 
disagrees with somewhat divergent epidemiological data by Chen et al. (2012) from very old 
(85 years) adults. This finding suggests that unadjusted differences in glucose by CMV status 
are likely a consequence of common predisposing factors, rather than being causally linked. 
Indeed, both CMV infection and dysregulated glucose metabolism are more common in those 
with a variety of pre-existing health risk factors. For example, CMV has a non-random 
distribution in the population, and infection is particularly prevalent among those who are 
typically older, current smokers, have low SES (job status, education) or ethnic minority 
status (Dowd et al., 2009; Simanek et al., 2009; Stadler et al., 2010). On the other hand, the 
robust linear relationships between HbA1c and EM and EMRA T-cells found with only within 
CMV+ individuals suggest glycemic status may contribute to immune responses to CMV 
reactivation rather than initial infection. 
 The current positive relationship between markers of dyslipidemia and numbers of 
dCTL among CMV+ individuals appears to partly be a by-product of the intrinsic link 
between HbA1c and lipid metabolism found in both diabetic (Ahmad Khan, 2007; Khan et al., 
2007; Ladeia et al., 2006; Vinodmahato et al., 2011) and non-diabetic adults (Selvin et al., 
2010). This relationship is evidenced by the null associations between triglycerides and dCTL 
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numbers among CMV+ individuals after additional adjustment for HbA1c in the current 
study. In contrast, the cholesterol-EM association survived additional adjustment for HbA1c, 
making a more direct effect of CMV more plausible. The factors underlying this association 
are not clear, but could reflect the manifestation of a host defense mechanism to limit CMV 
infectivity. As intracellular cholesterol is necessary for enhanced CMV virus production and 
effective entry into other cells (Chukkapalli et al., 2012; Heaton & Randall, 2011; Williamson 
et al., 2011; Zhang et al., 2013), the reduction of cellular cholesterol uptake by the host cell 
could explain the association of elevated cholesterol with EM accumulation here (Gudleski-
O'regan et al., 2012; Juckem et al., 2008). This does not, however, rule out the strong 
relationship between lipid and glucose metabolism, and combined effects are also possible. 
The current finding that CMV+ individuals with higher HbA1c and CVD risk factors 
(cholesterol and triglyceride levels) had elevated dCTL provides further evidence to a 
common impact of both CMV (Gkrania-Klotsas et al., 2012; Savva et al., 2013; Van De Berg 
et al., 2012) and dysregulated glucose metabolism (Adams et al., 2009; Barr et al., 2009; Barr 
et al., 2007; Eskesen et al., 2013) on cardiac health. Consistent with this notion, studies have 
found associations between circulating dCTL, CMV-specific T-cell responses and increased 
CVD risk factors, such as heart valve calcification, carotid artery thickness, and increased 
blood pressure (Hsue et al., 2006; Terrazzini et al., 2013; Winchester et al., 2011). Taken 
together, these findings support the hypothesis proposed by Simanek et al. (2011) that CMV 
infection and inflammation partially impact mortality risk via their combined contribution to 
other CVD risk factors, and further propose dysregulated glucose metabolism and increased 
dCTL as additional mechanisms.  
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There are a number of limitations with the current study that should be acknowledged. 
Firstly, the low number of diabetic participants precluded their inclusion as a separate group; 
comparisons were instead performed between normoglycemic and a merged hyperglycemic 
group. Information about whether these participants had Type I or Type II diabetes was also 
not available. However, clinically relevant markers of immunosenescence (e.g., short telomere 
length) are observed even at early stages of glucose dysregulation (Adaikalakoteswari et al., 
2007; Salpea & Humphries, 2010; Salpea et al., 2010), and the associations found in 
hyperglycemic individuals were not altered by the removal of the diabetic group from the 
analyses. Secondly, there was no direct measure of subsequent CMV reactivation. 
Nevertheless, the selective EMRA T-cell accumulation is almost exclusively associated with 
CMV infection, and there is a strong empirical basis to suggest that these associations are 
reflections of CMV activity (Cantisán et al., 2010; Chidrawar et al., 2009; Derhovanessian et 
al., 2011; Turner et al., 2014; Van De Berg et al., 2008; Van Lier et al., 2003). However, 
future studies should include more direct measures of CMV reactivation (e.g., quantitative 
CMV-specific antibody levels) for comparison. Finally, due to the cross-sectional nature of 
the study, we are unable to discern cause-and-effect relationships. Given the complex 
interplay between components of the immune system, metabolic factors, CMV, and aging, as 
well as the contribution of potential intermediaries such as oxidative stress and inflammation 
to these processes, bi-directional or cyclical relationships between these factors cannot be 
ruled out. 
In conclusion, in the largest study to-date, we observed associations between measures 
of glucose metabolism (i.e., HbA1c and diabetic status), dyslipidemia (total cholesterol and 
triglycerides), and dCTL subsets among CMV+ individuals. These associations with HbA1c 
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withstood adjustment for demographic, SES, and lifestyle factors known to impact both CMV 
infection and glucose metabolism, demonstrating a robust association. Overall, it appears that 
these metabolic factors act reciprocally with CMV to amplify the accumulation of EM and 
EMRA CD8+ T-cells, and represent potentially biologically relevant pathways underlying the 
CMV-induced acceleration of immunosenescence.  
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CHAPTER 7 : GENERAL DISCUSSION 
Summary of main findings 
This thesis set out to explore the psychosocial and behavioral determinants of immune 
aging in a large sample of working-aged adults. Specifically, CMV infection and its 
reactivation were considered as a shared pathway between these factors and 
immunosenescence. The data presented in the first two empirical chapters (Chapters 3 and 4) 
were drawn from MICS 2007 using as outcomes, CMV serostatus and CMV reactivation, 
measured as levels of CMV-IgG antibody. Chapter 3 shows that increases in self-reported 
measures of psychological stress are associated with higher CMV-IgG levels among those 
infected. On the other hand, it was the socio-demographic and lifestyle factors, (i.e., SES, 
marital status, and smoking) that associated with higher odds of initial CMV infection. These 
associations appeared to be independent of HPA-axis and inflammatory activity. Chapter 4 
revealed that those reporting higher levels of conscientiousness had lower CMV-IgG levels, 
while those higher in neuroticism had increased odds of CMV infection. These associations 
were apparent after mutual adjustment for the other Big 5 personality traits and were not 
explained by SES or lifestyle factors.  
The data presented in chapters 5 and 6 were drawn from the MICS 2011 dataset using 
the accumulation of highly-differentiated T-cells as a measure of immunosenescence. Chapter 
5 revealed that increased frequency of physical activity is associated with decreased 
accumulation of highly-differentiated T-cells, which was observed only in those in the upper 
two age tertiles. Adjustment for CMV status attenuated all linear associations with highly-
differentiated T-cells, except the lower EMRA γδ T-cells observed with increased moderate 
physical activity. Chapter 6 showed that impaired glycemic control interacted with CMV to 
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enhance the accumulation of highly-differentiated T-cells among CMV+ individuals. The 
above associations remained significant after adjustment for potential confounders, suggesting 
a robust effect. 
Collectively, the data in this thesis provide evidence in support of the notion that 
whatever dictates CMV reactivation may, in turn, influence the aging of the immune system 
(Nikolich-Zugich, 2008). Specifically, it appears that psychosocial and behavioral factors may 
be such relevant determinants of CMV activity, and thereby, of immunosenescence. In recent 
years it has become increasingly clear that incessant antigenic stimulation by herpes viruses, 
in particular CMV, is a major driving force of senescence within the T-cell compartment. This 
immune dominance is evident among those infected in the dramatic expansion of CMV-
specific T-cells displaying a highly-differentiated phenotype (e.g., CD45RA+/-CD27-); a 
hallmark of immune aging. Thus, the associations found between these psychosocial and 
behavioral factors and these outcomes may help to substantiate this claim. 
Psychosocial and behavioral factors interact to determine CMV activity 
The data appear to reveal a pattern, whereby some of these factors promote CMV 
reactivation (psychological stress and dysregulated metabolism), while others play a 
protective role (conscientiousness and physical activity), working to keep the virus in latency. 
Considering the potentially opposing effects of the factors studied here, it is tempting to 
speculate that CMV reactivation may reflect the imbalance of this dynamic relationship. 
Below, I describe how the factors increasing or decreasing CMV reactivation are 
interconnected, and speculate that these factors may work against one another to co-determine 
the set-point for CMV activity and the progression of immunosenescence.  
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Psychological stress and glucose metabolism 
Observations from the stress-metabolism literature suggest that the observed increase 
in CMV activity with both stress and HbA1c may be two sides of the same coin; that is, 
chronic psychological stress could possibly exacerbate the effects of dysregulated glucose 
metabolism. Psychological stress is characterized by a shift in the hormonal balance towards 
an increasingly catabolic state (Epel, 2009), resulting in excessive release of endogenous 
substrates, including glucose, into the periphery, disproportionate to metabolic needs (Balanos 
et al., 2010; Carroll et al., 2009; Laugero, 2008). Indeed, a recent study by Li et al. (2013) 
showed that increased work stress was associated with increased odds of pre-diabetes and 
diabetes in men. HbA1c reflects this chronic elevation in glucose and, consequently, has been 
proposed as a physiological marker of psychological stress (Schuck, 1998). Therefore, 
psychological stress may not only stimulate the CMV IE promoter region by mediators of the 
HPA- and SAM-axis (i.e., glucocorticoids and catecholamines), but also enhance CMV 
reactivation via stress-induced hyperglycemia and the related oxidative stress pathways 
described in chapter 6.  
Conscientiousness and physical activity  
The protective effects of conscientiousness and physical activity also have 
complimentary features, and together, may oppose the above effects of stress and dysregulated 
metabolism on CMV reactivation and immunosenescence. Certainly, conscientiousness is 
associated with more favorable metabolic profile, and may exact its action, in part, through 
health-behaviors, including better dietary choices (Tiainen et al., 2013; Wen et al., 2015), 
abstinence from smoking (Martin et al., 2007) and importantly, a physically active lifestyle 
(Chatzisarantis & Hagger, 2008; Rhodes & Smith, 2006). Physical exercise is also known to 
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counteract the debilitating physiological effects of psychological stress on the body (Phillips 
et al., 2007). For example, chronic stress has been associated with increased adiposity, 
oxidative stress, circulating levels of cortisol and pro-inflammatory cytokine production 
(Djuric et al., 2008; Epel, 2009; Laugero, 2008). Physical activity, in contrast, increases lipid 
metabolism, improves anti-oxidant capacity, increases DHEA production, and induces an anti-
inflammatory environment with each successive bout (Lawler & Powers, 1998; Pedersen, 
2009; Pedersen & Febbraio, 2008; Phillips et al., 2007; Rowinski et al., 2013). These 
consequences of chronic stress are known to increase CMV reactivation, and may therefore be 
a plausible mechanism by which the current results with conscientiousness and physical 
activity can be attributed.  
Both conscientiousness and physical activity also effectively enhance stress resilience. 
Those high in conscientiousness are reported to have a reduced frequency of stress exposure, 
which may stem from decreased appraisal of stressors as threats, and to utilize better coping 
strategies (Bartley & Roesch, 2011; Gartland et al., 2012; Murphy et al., 2013). Physical 
exercise not only alleviates measures associated with chronic stress, such as anxiety and 
depression (Rethorst et al., 2009; Wipfli et al., 2008), but can also buffer physiological 
responses to acute psychological stressors. Although the literature regarding the immune 
system is largely mixed, evidence accrued from studies on the so-called ‘cross-stressor 
adaptation hypothesis’ supports the beneficial effects of an exercise training program on 
cardiovascular and endocrine stress responses to a subsequent acute social stressor (Klaperski 
et al., 2013, 2014). This protection against stress effects, including both chronic metabolic 
alterations and acute stress reactivity may reduce the toll that psychological stressors take on 
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the body and could, in part, account for the lowered CMV reactivation observed with 
increased conscientiousness and physical activity. 
On the other hand, evidence exists that supports a bi-directional relationship between 
these factors. Chronic stress has been shown to affect the frequency of participation in 
physical activity and exercise (Martins & Lopes, 2013; Stults-Kolehmainen & Sinha, 2014). 
For instance, a recent survey across 16 US states revealed that those individuals with serious 
psychological distress were less likely to meet recommended levels of physical activity 
(Okoro et al., 2014). Additionally, increased depressive symptoms have been found to 
mitigate the anti-inflammatory benefits of leisure-time physical activity on hs-CRP levels 
(Suarez et al., 2013). It is also worthy of mention that among people high in conscientiousness 
(i.e., one standard deviation above the mean), chronic interpersonal stress was associated with 
increased glucocorticoid resistance (Murphy et al., 2013). In these situations, the effects of 
stress would tip the scales in favor of immune dysregulation and could culminate in increased 
CMV reactivation. These findings reinforce the idea that these factors are in competition with 
one another to establish equilibrium; the outcome of which is reflected in CMV reactivation. 
Determinants of CMV infection 
CMV infection may represent a biological link between psychosocial and behavioral 
factors, disease and mortality. Across both the 2007 and 2011 cohorts, those infected with 
CMV are characterized as older, married individuals that have lower socioeconomic status and 
make poorer lifestyle choices (e.g., smoking). In the 2007 sample, CMV+ individuals were 
more neurotic than those uninfected, and in the 2011 sample, they were more likely to be 
female, less physically active, to drink alcohol less frequently, to have lower HDL-C levels 
and to be classified as hyperglycemic or diabetic. Overall, this archetype of CMV-infected 
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individuals bears striking resemblance to the profiles of high-risk populations for several 
comorbidities, including cardiovascular disease, cognitive decline, cancer, as well as increased 
mortality (Hausenloy & Yellon, 2008). That is, the factors predicting these disease states 
likewise predispose individuals to initial CMV infection. While these factors may 
progressively lead to disease by themselves, additional CMV infection would drastically 
enhance pathogenesis via accelerated immunosenescence, providing a ‘double-whammy’. 
This observation could arguably explain links between these predictors of CMV infection and 
increased mortality risk. For instance, the health effects of neuroticism, agreeableness and low 
SES have been found to be largely explained by health-behaviors (i.e., smoking, and physical 
inactivity), which are, in turn, associated with increased CMV infection odds (Chapman et al., 
2010; Mroczek et al., 2009; Shipley et al., 2007). Although not studied explicitly here, the 
considerable overlap between these factors gives credence to the notion that CMV infection 
may co-determine the pathogenesis of disease and increased mortality. 
These findings suggest that CMV serostatus could also be used as a sensitive 
biomarker for disease risk. Interestingly, CMV infection was accompanied by increases in 
some risk factors for cardiovascular disease, like low HDL-C, diabetes, low SES, smoking, 
and less alcohol intake, but did not differ in other classic risk factors, such as obesity (i.e., 
BMI, waist-to-hip ratio), triglycerides, total cholesterol, blood pressure, resting heart rate. If 
applied as a screening tool, CMV serostatus may discriminate between at-risk populations in 
the absence of overt manifestations of physical dysregulation. This prospect could better 
inform treatment protocols, allow for earlier intervention and improve the prevention of 
numerous diseases. Therefore, it is proposed here that the public health implications of 
including CMV in basic screening panels in hospitals could be significant. Some potential 
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actions could be to supplement standard regimens with stress reduction, exercise, or 
nutritional interventions to reduce the reactivation of CMV in those infected, possibly 
improving prognosis for their other ailments. Monitoring CMV-IgG levels could potentially 
help assess the efficacy of such interventions on immune functioning (cf. Moro-Garcia et al., 
2013). 
Limitations and future directions 
Limitations 
A limitation of this thesis is that, due to the available data for each outcome (i.e., 
CMV-IgG and T-cell accumulation), these studies were not able to directly link all the 
psychosocial and behavioral factors to immunosenescence in one model. Although 
subcomponents of this model have been confirmed (i.e., stress and latent herpes reactivation, 
and the role of CMV infection in development of immunosenescence), the full model still 
awaits empirical scrutiny. The interconnectedness of the factors examined here provides a 
strong basis for their inclusion as predictors in future studies. These studies may benefit from 
a structural equation modelling approach with latent variables representing the constructs of 
psychological stress, personality, SES, physical activity, and metabolism to clarify their 
relationship to CMV infection, reactivation, and immunosenescence. This scrutiny seems 
worthwhile as confirmation will have significant implications for our understanding of the 
links between stress and immunity. One of its main implications would perhaps be that the 
host’s infection history is an important, and thus far overlooked, mediator of these links. 
Another limitation is that the cross-sectional study design does not allow for causality 
to be inferred. The hypothesized model is based on the current literature demonstrating CMV 
reactivation as a result of the factors examined, and the data presented here are consistent with 
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that orientation. Nevertheless, it still remains conceivable that the relationships between these 
factors and CMV are bi-directional or even cyclical. The latter has been demonstrated for 
another herpes virus (HSV-2), whereby reactivation was both a cause and a consequence of 
psychological distress (Strachan et al., 2011). Two major challenges for future investigations 
seeking these causal confirmations lie in the ubiquitous nature of CMV in the population 
(Dowd et al., 2009) and uncertainty about how long an individual has had CMV (due to early-
life infection). While the former is difficult to tackle, attempts to address the latter have 
utilized longitudinal study designs in newly-infected transplant patients to circumvent these 
issues, but the populations presumably have many other potential confounders, preventing 
generalization to healthy adults. Perhaps future studies could measure CMV activity in 
parallel with the abovementioned factors (pre- and post-infection) among incoming university 
freshmen to discern the effects of infection and/or reactivation on the parameters studied 
herein and vice versa.  
A potential next step 
One consideration that could build upon the findings here is that CMV may also alter 
psychobiological responses to stress; in particular, stress-induced lymphocytosis. 
Lymphocytosis is probably one of the best documented effects of stress on the immune 
system; it involves a rapid (within minutes) increase in the absolute number of lymphocytes in 
the peripheral blood (Benschop et al., 1996; Bosch et al., 2005; Dhabhar & Mcewen, 1999). 
Lymphocytosis is driven by β-adrenergic mechanisms, and the lymphocyte subsets that show 
the strongest mobilization during stress exhibit the highest β2-adrenergic receptor (β2AR) 
density and cytotoxic ability, such as natural killer (NK) cells and CD8+ T lymphocytes 
(CTLs), and also γδ T-cells and the small subset of cytotoxic CD4+ T-cells (Anane et al., 
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2009; Campbell et al., 2009; Elenkov et al., 2000). Coincidentally, these are the same cell 
types that become strongly enriched in peripheral blood as a result of CMV infection. Indeed, 
Riddell (2010) found in CMV-positive hosts that CMV-specific CTLs had a greater 
propensity to mobilize than total CTLs in response to acute stress, and that they contained a 
larger proportion of EM (CD45RA-CD27-) and EMRA (CD45RA+CD27-) cells (Riddell, 
2010). This strong and robust mobilization of the stress sensitive, highly-differentiated EM 
and EMRA populations evoked by acute psychological stress is likely explained by their 
increased expression of the β2AR (Dimitrov et al., 2009; Dimitrov et al., 2010).  
While a fascinating physiological phenomenon, it is still unknown if the enhanced 
stress-induced recruitment of cytotoxic cells in CMV+ individuals has any immunological or 
clinical impact, such as regulation of inflammation or viral control. There is evidence to 
suggest that the enhanced β-adrenergic sensitivity of CMV-specific CTLs may directly impact 
viral control, as adrenergic stimulation of T-cells can alter a variety of effector functions 
including proliferation, lytic activity, and cytokine production (Bartik et al., 1993; Borger et 
al., 1998; Glaser & Kiecolt-Glaser, 2005; Gratama et al., 2008; Hatfield et al., 1986; 
Kalinichenko et al., 1999; Leo & Bonneau, 2000; Lilleri et al., 2008; Morita-Hoshi et al., 
2008; Ozdemir et al., 2002; Sarid et al., 2001, 2004; Sekut et al., 1995). One may speculate, 
therefore, that the amplification of cytotoxic lymphocyte mobilization during stressful events 
in CMV+ individuals may be conducive to elevated systemic inflammation whilst also 
decreasing antigen-specific immunity; both of which are hallmarks of immunosenescence. 
Future studies correlating the CMV-induced accumulation of highly-differentiated T-cells, the 
frequency and magnitude of responses to acute stressors, and outcomes in clinical populations, 
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such as cardiovascular disease, cancer and autoimmune disease patients could be informative 
in this regard.   
Conclusion 
The data in this thesis support psychosocial and behavioral factors as determinants of 
immune aging, with CMV infection and its reactivation representing a common biological 
pathway. Taken as a whole, the results show a pattern that can be likened to a reverberating 
circuit in which the factors studied here may induce, perpetuate or combat CMV reactivation 
and immunosenescence. First, inter-related predisposing factors, such as neuroticism, low 
socioeconomic status, smoking, and physical inactivity, increase the odds of initial CMV 
infection. Once infected, elevations in other factors, such as psychological stress and impaired 
glycemic control, occur concomitantly with CMV reactivation from latency, thereby 
accelerating the accumulation of highly-differentiated T-cells. The by-products of this 
process, such as inflammatory mediators, provide positive feedback to the cycle and propagate 
more damage, resulting in increased disease and mortality risk. Other factors, such as 
conscientiousness and physical activity, may work to interrupt this detrimental cycle and 
restore balance to the system. Thus, the current results suggest that CMV infection history 
may play an insidious role in determining disease and mortality. There may be hope in the 
form of improved screening, intervention and prevention of CMV effects on immune aging; 
this may be of particular relevance in immune-compromised individuals, such as HIV 
patients, transplant recipients and critically-ill populations. Future studies in these areas 
should take a more integrated, rather than piecemeal, approach while accounting for the 
impact of CMV activity on immunity, health and longevity.  
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